[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 4766
1. Zhang HJ, Siu MK, Wong ES, Wong KY, Li AS, Chan KY, Ngan HY, Cheung AN: Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. Placenta; 2008 Jun;29(6):549-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • By methylation-specific PCR, we observed both methylated and unmethylated Oct4 alleles in all 25 first trimester and 10 term placentas while 33% (18/54) of hydatidiform moles, and two choriocarcinoma cell line (JEG3 and JAR), only displayed methylated Oct4 allele.
  • By quantitative TaqMan real-time PCR, Oct4 mRNA was significantly reduced in hydatidiform moles (P=0.04), JEG3 and JAR (P=0.024) when compared with normal placentas.

  • Genetic Alliance. consumer health - Gestational Trophoblastic Disease.
  • Hazardous Substances Data Bank. AZACITIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18440631.001).
  • [ISSN] 0143-4004
  • [Journal-full-title] Placenta
  • [ISO-abbreviation] Placenta
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; 0 / Hydroxamic Acids; 0 / Octamer Transcription Factor-3; 0 / POU5F1 protein, human; 0 / RNA, Messenger; 3X2S926L3Z / trichostatin A; 776B62CQ27 / decitabine; EC 2.1.1.- / DNA Modification Methylases; M801H13NRU / Azacitidine
  •  go-up   go-down


2. Malowicki MG, Shellhammer TH: Isomerization and degradation kinetics of hop (Humulus lupulus) acids in a model wort-boiling system. J Agric Food Chem; 2005 Jun 1;53(11):4434-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Activation energy was experimentally determined to be 98.6 kJ per mole for isomerization, and 108.0 kJ per mole for degradation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15913306.001).
  • [ISSN] 0021-8561
  • [Journal-full-title] Journal of agricultural and food chemistry
  • [ISO-abbreviation] J. Agric. Food Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acids; 0 / Cyclohexenes; 0 / Solutions; 0 / Terpenes; KHB4767H3K / humulon
  •  go-up   go-down


3. Martí N, Jordá E, Martínez E, Gámez L, Ramón MD: Widespread nevus spilus associated with torsion dystonia: a case report. Pediatr Dermatol; 2010 Nov-Dec;27(6):654-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Widespread nevus spilus associated with torsion dystonia: a case report.
  • Usually speckled lentiginous nevus or nevus spilus is a small solitary lesion consisting of a light tan patch with numerous dark brown macules or papules (or both) within it.
  • It is occasionally associated with complex birth defects such as phacomatosis pigmentovascularis, phacomatosis pigmentokeratotica, or speckled lentiginous nevus syndrome.
  • We hereby report a 6-year-old Caucasian patient with systematized nevus spilus associated with torsion dystonia, a combination not published thus far.
  • [MeSH-major] Dystonia Musculorum Deformans / complications. Nevus, Pigmented / complications. Skin Neoplasms / complications


Advertisement
4. Mathias RT, Wang H: Local osmosis and isotonic transport. J Membr Biol; 2005 Nov;208(1):39-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osmotically driven water flow, u (cm/s), between two solutions of identical osmolarity, c(o) (300 mM: in mammals), has a theoretical isotonic maximum given by u = j/c(o), where j (moles/cm(2)/s) is the rate of salt transport.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Physiol. 2002 Jul 1;542(Pt 1):53-60 [12096049.001]
  • [Cites] J Gen Physiol. 1964 Sep;48:15-42 [14212146.001]
  • [Cites] J Gen Physiol. 1967 Sep;50(8):2061-83 [6066064.001]
  • [Cites] J Theor Biol. 1970 Nov;29(2):233-50 [5500469.001]
  • [Cites] J Gen Physiol. 1975 Dec;66(6):671-733 [1104761.001]
  • [Cites] J Membr Biol. 1981 May 15;60(1):1-20 [6264088.001]
  • [Cites] Am J Physiol. 1984 Feb;246(2 Pt 2):F167-74 [6696118.001]
  • [Cites] Nature. 1962 Jan 27;193:347-8 [13882705.001]
  • [Cites] J Gen Physiol. 1960 Jul;43:1137-48 [13813357.001]
  • [Cites] J Membr Biol. 2005 Jan;203(1):41-56 [15834688.001]
  • [Cites] J Gen Physiol. 2000 Aug;116(2):101-24 [10919860.001]
  • [Cites] Pflugers Arch. 2000 Aug;440(4):513-20 [10958335.001]
  • [Cites] J Physiol. 2001 Mar 15;531(Pt 3):631-44 [11251046.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3628-30 [11274376.001]
  • [Cites] J Membr Biol. 2002 May 1;187(1):37-50 [12029376.001]
  • [Cites] J Physiol. 2002 Jul 1;542(Pt 1):51 [12096048.001]
  • [Cites] Am J Physiol. 1984 Jul;247(1 Pt 2):F117-29 [6331196.001]
  • [Cites] J Gen Physiol. 1985 May;85(5):699-728 [3998707.001]
  • [Cites] Biophys J. 1985 Jun;47(6):823-36 [4016200.001]
  • [Cites] Acta Physiol Scand. 1989 Jul;136(3):443-54 [2473601.001]
  • [Cites] Am J Physiol. 1989 Nov;257(5 Pt 1):C837-50 [2688434.001]
  • [Cites] Physiol Rev. 1997 Jan;77(1):21-50 [9016299.001]
  • [Cites] J Physiol. 1998 Apr 1;508 ( Pt 1):15-21 [9490810.001]
  • [Cites] J Membr Biol. 1999 Apr 1;168(3):241-51 [10191358.001]
  • [Cites] J Membr Biol. 1999 Aug 1;170(3):191-203 [10441663.001]
  • [Cites] Nat Rev Mol Cell Biol. 2004 Sep;5(9):687-98 [15340377.001]
  • (PMID = 16596445.001).
  • [ISSN] 0022-2631
  • [Journal-full-title] The Journal of membrane biology
  • [ISO-abbreviation] J. Membr. Biol.
  • [Language] ENG
  • [Grant] United States / NEI NIH HHS / EY / R01 EY006391; United States / NEI NIH HHS / EY / EY06391
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Isotonic Solutions
  • [Other-IDs] NLM/ NIHMS9554; NLM/ PMC1752196
  •  go-up   go-down


5. Asher RJ, Lehmann T: Dental eruption in afrotherian mammals. BMC Biol; 2008;6:14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, morphological data uniting its diverse constituents, including elephants, sea cows, hyraxes, aardvarks, sengis, tenrecs and golden moles, have been difficult to identify.
  • RESULTS: Although data on the absolute timing of eruption in sengis, golden moles and tenrecs are still unknown, craniometric comparisons for ontogenetic series of these taxa show that considerable skull growth takes place prior to the complete eruption of the permanent cheek teeth.
  • Specimens showing less than half (sengis, golden moles) or two-thirds (tenrecs, hyraxes) of their permanent cheek teeth reach or exceed the median jaw length of conspecifics with a complete dentition.
  • CONCLUSION: Morphological characteristics shared by such physically disparate animals such as elephants and golden moles are not easy to recognize, but are now known to include late eruption of permanent teeth, in addition to vertebral anomalies, testicondy and other features.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Anat Rec (Hoboken). 2007 Jun;290(6):624-37 [17516429.001]
  • [Cites] Proc Biol Sci. 2007 May 7;274(1614):1159-66 [17329227.001]
  • [Cites] BMC Evol Biol. 2007;7:108 [17608930.001]
  • [Cites] BMC Evol Biol. 2007;7:224 [17999766.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14444-8 [11121045.001]
  • [Cites] Hum Mutat. 2002 Mar;19(3):209-16 [11857736.001]
  • [Cites] Arch Oral Biol. 2003 Sep;48(9):673-7 [12888002.001]
  • [Cites] Dev Biol. 2004 Jun 1;270(1):76-93 [15136142.001]
  • [Cites] Genet Couns. 2004;15(2):229-31 [15287425.001]
  • [Cites] J Dent Res. 1967 Jan-Feb;46(1):276-8 [5226398.001]
  • [Cites] J Oral Pathol Med. 1990 Feb;19(2):89-93 [2341976.001]
  • [Cites] Cell. 1997 May 30;89(5):765-71 [9182764.001]
  • [Cites] Cell. 1997 May 30;89(5):773-9 [9182765.001]
  • [Cites] J Theor Biol. 1999 Jan 7;196(1):61-72 [9892556.001]
  • [Cites] J Med Genet. 1999 Mar;36(3):177-82 [10204840.001]
  • [Cites] Development. 1999 Jul;126(13):2911-20 [10357935.001]
  • [Cites] Nature. 2004 Nov 11;432(7014):211-4 [15538367.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Dec 28;101(52):18058-63 [15596718.001]
  • [Cites] J Dent Res. 2005 Feb;84(2):138-43 [15668330.001]
  • [Cites] J Exp Zool B Mol Dev Evol. 2005 Mar 15;304(2):91-106 [15660398.001]
  • [Cites] Birth Defects Res C Embryo Today. 2005 Sep;75(3):213-25 [16187316.001]
  • [Cites] Nature. 2005 Dec 8;438(7069):803-19 [16341006.001]
  • [Cites] J Exp Zool B Mol Dev Evol. 2006 Mar 15;306(2):140-63 [16254985.001]
  • [Cites] Biol Rev Camb Philos Soc. 2007 Aug;82(3):375-92 [17624960.001]
  • (PMID = 18366669.001).
  • [ISSN] 1741-7007
  • [Journal-full-title] BMC biology
  • [ISO-abbreviation] BMC Biol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2292681
  •  go-up   go-down


6. Gönül M, Soylu S, Gül U, Aslan E, Unal T, Ergül G: Giant congenital melanocytic naevus associated with Dandy-Walker malformation, lipomatosis and hemihypertrophy of the leg. Clin Exp Dermatol; 2009 Jul;34(5):e106-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant congenital melanocytic naevus associated with Dandy-Walker malformation, lipomatosis and hemihypertrophy of the leg.
  • Malignant melanoma was excluded by histopathological examinations of multiple biopsy specimens obtained from the pigmented lesions.
  • Neurocutaneous melanosis is a rare combined abnormality of the skin and central nervous system.
  • A few case reports relating to the coexistence of giant congenital melanocytic naevus, lipomatosis and hemihypertrophy have been published in the literature.
  • We report this very rare case of giant melanocytic naevus with lipomatosis, hemihypertrophy of the leg, and DWM.
  • [MeSH-major] Dandy-Walker Syndrome / diagnosis. Leg / pathology. Lipomatosis / diagnosis. Neurocutaneous Syndromes / diagnosis. Nevus, Pigmented / diagnosis

  • Genetic Alliance. consumer health - Hemihypertrophy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19438567.001).
  • [ISSN] 1365-2230
  • [Journal-full-title] Clinical and experimental dermatology
  • [ISO-abbreviation] Clin. Exp. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


7. Hernández A, Torrelo A: [Recent data on the risk of malignancy in congenital melanocytic nevi: the continuing debate on treatment]. Actas Dermosifiliogr; 2008 Apr;99(3):185-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Recent data on the risk of malignancy in congenital melanocytic nevi: the continuing debate on treatment].
  • [Transliterated title] Ultimos datos sobre el riesgo de malignización de los nevus melanocíticos congénitos: el debate sobre el tratamiento continúa.
  • Congenital melanocytic nevi (CMN) have traditionally been considered a risk factor for the appearance of melanoma, but the true incidence of malignancy is unknown.
  • [MeSH-major] Nevus, Pigmented / congenital. Nevus, Pigmented / therapy. Skin Neoplasms / congenital. Skin Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Actas Dermosifiliogr. 2009 Jan-Feb;100(1):84-5 [19268122.001]
  • (PMID = 18358193.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 26
  •  go-up   go-down


8. Vaidya DC, Schwartz RA, Janniger CK: Nevus spilus. Cutis; 2007 Dec;80(6):465-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nevus spilus.
  • Nevus spilus (NS), also known as speckled lentiginous nevus (SLN), is a relatively common cutaneous lesion that is characterized by multiple pigmented macules or papules within a pigmented patch.
  • NS deserves its own place in the spectrum of classification of important melanocytic nevi; as a lentigo and melanocytic nevus, it has the slight potential to develop into melanoma.
  • [MeSH-major] Nevus, Pigmented. Skin Neoplasms
  • [MeSH-minor] Diagnosis, Differential. Humans. Melanoma / pathology. Prevalence


9. Smit NP, van Nieuwpoort FA, Marrot L, Out C, Poorthuis B, van Pelt H, Meunier JR, Pavel S: Increased melanogenesis is a risk factor for oxidative DNA damage--study on cultured melanocytes and atypical nevus cells. Photochem Photobiol; 2008 May-Jun;84(3):550-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased melanogenesis is a risk factor for oxidative DNA damage--study on cultured melanocytes and atypical nevus cells.
  • Clinical atypical (dysplastic) nevi (DN) regularly contain more melanin than do normal melanocytes (MC).
  • [MeSH-major] DNA Damage. Dysplastic Nevus Syndrome / pathology. Melanins / biosynthesis. Melanocytes / radiation effects. Reactive Oxygen Species / metabolism. Ultraviolet Rays / adverse effects
  • [MeSH-minor] Cells, Cultured. Humans. Oxidative Stress / radiation effects. Pigmentation. Risk Factors. Skin / cytology

  • Genetic Alliance. consumer health - Nevus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18435613.001).
  • [ISSN] 0031-8655
  • [Journal-full-title] Photochemistry and photobiology
  • [ISO-abbreviation] Photochem. Photobiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Melanins; 0 / Reactive Oxygen Species
  •  go-up   go-down


10. Vazmitel M, Michal M, Mukensnabl P, Kazakov DV: Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion. Am J Dermatopathol; 2007 Dec;29(6):566-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
  • We present two cases of melanoma arising in a dysplastic nevus that contained intradermal sebocyte-like melanocytes characterized by a scalloped dark-staining nucleus surrounded by the pale multivacuolated cytoplasm imitating sebaceous differentiation.
  • Microscopically, both cases had the following features in common: the melanoma in situ, which was of the superficially spreading type, was associated with a dysplastic compound nevus, in which the sebocyte-like cells were identified in the intradermal nevus part of the lesion.
  • The sebocyte-like cells comprised a minor component but were immediately recognizable and appeared as cells with multivacuolated neoplasm and scalloped nuclei arranged in nests.
  • The conventional part of the nevi demonstrated the same phenotype, with the exception of the melanocytic nests located at the dermoepidermal junction that were HMB-45 positive.
  • [MeSH-major] Dysplastic Nevus Syndrome / pathology. Melanocytes / pathology. Melanoma / pathology. Sebum / cytology. Skin Neoplasms / pathology
  • [MeSH-minor] Antigens, Neoplasm / metabolism. Biomarkers, Tumor / metabolism. Female. Humans. MART-1 Antigen. Middle Aged. Neoplasm Proteins / metabolism. Neoplasms, Multiple Primary. S100 Proteins / metabolism

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18032954.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Neoplasm Proteins; 0 / S100 Proteins
  •  go-up   go-down


11. Morris C, Wood P, Griffiths SL, Wilson KS, Ashton AW: MOLE: a data management application based on a protein production data model. Proteins; 2005 Feb 1;58(2):285-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MOLE: a data management application based on a protein production data model.
  • MOLE (mining, organizing, and logging experiments) has been developed to meet the growing data management and target tracking needs of molecular biologists and protein crystallographers.
  • To achieve this, MOLE is based on the data model for protein production devised at the European Bioinformatics Institute (Pajon A, et al., Proteins in press).

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2004 Wiley-Liss, Inc.
  • (PMID = 15468326.001).
  • [ISSN] 1097-0134
  • [Journal-full-title] Proteins
  • [ISO-abbreviation] Proteins
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


12. Tanese K, Wakabayashi A, Suzuki T, Miyakawa S: Immunoexpression of human epidermal growth factor receptor-2 in apocrine carcinoma arising in naevus sebaceous, case report. J Eur Acad Dermatol Venereol; 2010 Mar;24(3):360-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoexpression of human epidermal growth factor receptor-2 in apocrine carcinoma arising in naevus sebaceous, case report.
  • [MeSH-major] Carcinoma / immunology. Neoplasms, Multiple Primary / immunology. Nevus, Sebaceous of Jadassohn / immunology. Receptor, ErbB-2 / biosynthesis. Skin Neoplasms / immunology. Sweat Gland Neoplasms / immunology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19703100.001).
  • [ISSN] 1468-3083
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 2.7.10.1 / ERBB2 protein, human; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


13. Rosenbusch B: Co-existence of a diploid hydatidiform mole and a normal fetus: mysterious events at the pronuclear stage. Hum Reprod; 2008 Dec;23(12):2876-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Co-existence of a diploid hydatidiform mole and a normal fetus: mysterious events at the pronuclear stage.
  • [MeSH-minor] Diseases in Twins / genetics. Female. Humans. Hydatidiform Mole / genetics. Male. Models, Genetic. Pregnancy. Zygote / physiology

  • Genetic Alliance. consumer health - Hydatidiform mole.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Hum Reprod. 2008 Sep;23(9):2031-5 [18556678.001]
  • (PMID = 18927128.001).
  • [ISSN] 1460-2350
  • [Journal-full-title] Human reproduction (Oxford, England)
  • [ISO-abbreviation] Hum. Reprod.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] England
  •  go-up   go-down


14. Coras B, Landthaler M, Stolz W, Vogt T: Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology. Am J Dermatopathol; 2010 Aug;32(6):599-602
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology.
  • Site-specific histopathology features have been reported for acral, auricular, flexural, and genital melanocytic nevi, however, to the best of our knowledge, site- and sex-specific histology of dysplastic nevi on the lower leg (between knee and ankle) of women (DN-LW) has not been reported.
  • In this retrospective histopathology study, we compared DN-LW (N = 42) with appropriate control groups of (1) DN of the lower leg of men (N = 20; DN-LM), (2) DN from the back of women (N = 20), (3) common nevi of the lower leg of women (N = 40), and (4) levels 1-2 superficial spreading melanoma of the lower leg of women (N = 20).
  • Compared with dysplastic nevi on the back, DN-LW were smaller in diameter and exhibited a significantly higher score for pagetoid spread (P < 0.05).
  • DN-LW compared with DN-LM showed sex-specific differences with (1) pagetoid spread (P < 0.05), (2) cytologic atypia (P < 0.05), (3) presence of large melanocytes (P < 0.05), and (4) band-like pigmentation in the dermis underlying the nevus (54% in DN-LW vs. 15% in DN-LM).
  • As with other body sites, the dermatopathologist should be aware that dysplastic nevi occurring on the lower leg in women have site- and sex-specific features.
  • Knowing this profile may lower the risk of misdiagnosing DN-LW and melanoma of the lower leg of women.
  • [MeSH-major] Diagnostic Errors / prevention & control. Dysplastic Nevus Syndrome / diagnosis. Melanocytes / pathology. Nevus, Pigmented / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Back. Diagnosis, Differential. Female. Humans. Leg. Male. Melanoma / diagnosis. Middle Aged. Retrospective Studies. Sex Factors. Young Adult

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Am J Dermatopathol. 2012 Dec;34(8):853-5 [22481498.001]
  • (PMID = 20534984.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Chen CY, Jafvert CT: Sorption of Buckminsterfullerene (C60) to saturated soils. Environ Sci Technol; 2009 Oct 1;43(19):7370-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because C60 is extremely hydrophobic, in this study the distribution between soil and mixtures of ethanol (EOH) and water were measured at ethanol mole fractions ranging from X(EOH) = 1.0-0.4 for two soils.

  • Hazardous Substances Data Bank. FULLERENES .
  • Hazardous Substances Data Bank. Water .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19848148.001).
  • [ISSN] 0013-936X
  • [Journal-full-title] Environmental science & technology
  • [ISO-abbreviation] Environ. Sci. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fullerenes; 0 / Soil; 0 / Soil Pollutants; 059QF0KO0R / Water; NP9U26B839 / fullerene C60
  •  go-up   go-down


16. Hoch LB, Mack EJ, Hydutsky BW, Hershman JM, Skluzacek JM, Mallouk TE: Carbothermal synthesis of carbon-supported nanoscale zero-valent iron particles for the remediation of hexavalent chromium. Environ Sci Technol; 2008 Apr 1;42(7):2600-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At a 10:3 Fe/Cr mole ratio, C-Fe0 reduced a 10 ppm Cr(VI) solution to approximately 1 ppm within three days.

  • MedlinePlus Health Information. consumer health - Iron.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • Hazardous Substances Data Bank. CARBON .
  • Hazardous Substances Data Bank. CHROMIUM, ELEMENTAL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18505003.001).
  • [ISSN] 0013-936X
  • [Journal-full-title] Environmental science & technology
  • [ISO-abbreviation] Environ. Sci. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0R0008Q3JB / Chromium; 7440-44-0 / Carbon; E1UOL152H7 / Iron
  •  go-up   go-down


17. Rodríguez G, González R, Gonzalez D, Granados C, Pinto R, Herrera H, Gutiérrez LF, Hernández E, López F, Gómez Y: [Active search for leprosy and other skin diseases in school children from Agua de Dios, Colombia]. Rev Salud Publica (Bogota); 2007 Jul-Sep;9(3):430-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Active search for leprosy and other skin diseases in school children from Agua de Dios, Colombia].
  • OBJECTIVE: Actively searching for leprosy, other skin diseases and BCG vaccination scars amongst school children from Agua de Dios, the municipality having the highest prevalence of leprosy in Colombia.
  • Skin smear tests and skin biopsies were performed when the clinical findings suggested leprosy.
  • RESULTS: 86 % of the 2 844 school children were examined; 833 had skin diseases and 16 % of these required evaluation by specialists.
  • Pediculosis capitis, pityriasis alba, tinea versicolor, hypopigmented nevus, insect bites and miliaria were frequently detected.
  • [MeSH-major] Leprosy / epidemiology. Mass Screening / methods. Skin Diseases / epidemiology. Students / statistics & numerical data

  • MedlinePlus Health Information. consumer health - Mycobacterial Infections.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18026607.001).
  • [ISSN] 0124-0064
  • [Journal-full-title] Revista de salud pública (Bogotá, Colombia)
  • [ISO-abbreviation] Rev Salud Publica (Bogota)
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Colombia
  •  go-up   go-down


18. Lode HM, Deeg KH, Krauss J: Spinal sonography in infants with cutaneous birth markers in the lumbo-sacral region--an important sign of occult spinal dysrhaphism and tethered cord. Ultraschall Med; 2008 Dec;29 Suppl 5:281-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The following cutaneous markers could be found: Asymmetrical gluteal crease (4); dermal sinus (2), hairy tuft (1); pigmented naevus (1); cutaneous appendage (1); haemangioma (1); unilateral peroneal paralysis with hypotrophic correspondic leg (1).

  • MedlinePlus Health Information. consumer health - Neural Tube Defects.
  • MedlinePlus Health Information. consumer health - Spina Bifida.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17610175.001).
  • [ISSN] 1438-8782
  • [Journal-full-title] Ultraschall in der Medizin (Stuttgart, Germany : 1980)
  • [ISO-abbreviation] Ultraschall Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


19. Blanchard-Fillion B, Prou D, Polydoro M, Spielberg D, Tsika E, Wang Z, Hazen SL, Koval M, Przedborski S, Ischiropoulos H: Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells. J Neurosci; 2006 Jun 7;26(23):6124-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Intracellular levels of 133 micromol of 3-nitrotyrosine per mole of tyrosine did not alter NT2 viability but induced PC12 apoptosis.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOPAMINE .
  • Hazardous Substances Data Bank. L-TYROSINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16763020.001).
  • [ISSN] 1529-2401
  • [Journal-full-title] The Journal of neuroscience : the official journal of the Society for Neuroscience
  • [ISO-abbreviation] J. Neurosci.
  • [Language] eng
  • [Grant] United States / NIA NIH HHS / AG / AG13966; United States / NHLBI NIH HHS / HL / HL076491; United States / NHLBI NIH HHS / HL / HL54926; United States / NINDS NIH HHS / NS / NS38370
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amino Acid Transport Systems; 0 / Dopamine Plasma Membrane Transport Proteins; 0 / Nitrophenols; 0 / Phenylacetates; 0 / Tubulin; 10463-20-4 / 4-hydroxy-5-nitrophenyl acetic acid; 3604-79-3 / 3-nitrotyrosine; 42HK56048U / Tyrosine; EC 1.4.3.4 / Monoamine Oxidase; EC 4.1.1.28 / Aromatic-L-Amino-Acid Decarboxylases; VTD58H1Z2X / Dopamine
  •  go-up   go-down


20. Behrends R, Fuchs K, Kaatze U, Hayashi Y, Feldman Y: Dielectric properties of glycerol/water mixtures at temperatures between 10 and 50 degrees C. J Chem Phys; 2006 Apr 14;124(14):144512
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • At six temperatures T between 10 and 50 degrees C and at mole fractions x(g) of glycerol (0<x(g)<or=0.9) the complex (electric) permittivity epsilon(nu) of glycerol/water mixtures has been measured as a function of frequency nu between 1 MHz and 40 GHz.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16626219.001).
  • [ISSN] 0021-9606
  • [Journal-full-title] The Journal of chemical physics
  • [ISO-abbreviation] J Chem Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Lutz BR, Chen J, Schwartz DT: Characterizing homogeneous chemistry using well-mixed microeddies. Anal Chem; 2006 Mar 1;78(5):1606-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A simple algebraic mole balance is combined with Raman spectroscopy measurements of oxidant concentration in the eddy and bulk to determine the reaction rate law and homogeneous rate constant (45 +/- 9 M(-1) s(-1)) for the antioxidant properties of vitamin C against ferricyanide.

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16503613.001).
  • [ISSN] 0003-2700
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Sutton VR, Hopkins BJ, Eble TN, Gambhir N, Lewis RA, Van den Veyver IB: Facial and physical features of Aicardi syndrome: infants to teenagers. Am J Med Genet A; 2005 Oct 15;138A(3):254-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Aicardi syndrome is a sporadic disorder that affects primarily females and is hypothesized to be caused by heterozygous mutations in an X-linked gene.
  • Various skin lesions (including multiple nevi, skin tags, hemangiomas, one giant melanotic nevus, and a history of a previously removed angiosarcoma) were present in 8/40 (20%).


23. Cardoso R, Massone C, Soyer HP, Hofmann-Wellenhof R: Additional dermoscopic presentation of haemosiderotic dermatofibroma. Br J Dermatol; 2007 Jan;156(1):199-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Dysplastic Nevus Syndrome / diagnosis. Histiocytoma, Benign Fibrous / diagnosis. Skin Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Dermatofibroma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Br J Dermatol. 2006 Feb;154(2):244-50 [16433792.001]
  • (PMID = 17199605.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Comment; Letter
  • [Publication-country] England
  •  go-up   go-down


24. Barbara KA, Buss EA: Integration of insect parasitic nematodes (Rhabditida steinernematidae) with insecticides for control of pest mole crickets (Orthoptera: Gryllotalpidae: Scapteriscus spp.). J Econ Entomol; 2005 Jun;98(3):689-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integration of insect parasitic nematodes (Rhabditida steinernematidae) with insecticides for control of pest mole crickets (Orthoptera: Gryllotalpidae: Scapteriscus spp.).
  • To develop a successful integrated pest management program for pest mole crickets (Orthoptera: Gryllotalpidae: Scapteriscus spp.
  • Aqueous solutions of five pesticides (acephate, bifenthrin, deltamethrin, fipronil, and imidacloprid) used in turfgrass to control mole crickets were tested for compatibility with Steinernema scapterisci Nguyen & Smart (Rhabditida: Steinernematidae) in the laboratory.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16022294.001).
  • [ISSN] 0022-0493
  • [Journal-full-title] Journal of economic entomology
  • [ISO-abbreviation] J. Econ. Entomol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Insecticides; 0 / Solutions
  •  go-up   go-down


25. Strauss RM, Elliott F, Affleck P, Boon AP, Newton-Bishop JA: A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions. Br J Dermatol; 2007 Oct;157(4):758-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.
  • BACKGROUND: Atypical naevi are common benign skin lesions but are also recognized both as precursors of and risk factors for melanoma.
  • It is therefore imperative to excise those lesions that are either likely to progress or are already progressing to melanoma.
  • Clinically, however, it may be difficult to distinguish these from benign atypical naevi with bland histology.
  • OBJECTIVES: To analyse the clinical characteristics of excised melanocytic lesions and to identify the predictors of severe histological atypia/melanoma in situ and invasive melanoma.
  • METHODS: The case notes of 434 patients who had melanocytic lesions removed at a pigmented lesion clinic were studied retrospectively.
  • RESULTS: The best predictors of melanoma were older age, history of change and site on an extremity, but only older age was predictive of severe histological atypia/melanoma in situ as opposed to mild to moderate atypical histology.
  • CONCLUSIONS: These results confirm the difficulty of differentiating accurately between benign atypical naevi and borderline lesions or early melanoma in a clinical setting.
  • [MeSH-major] Melanoma / pathology. Nevus, Pigmented / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Child. Diagnosis, Differential. Disease Progression. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Prognosis. Retrospective Studies. Risk Factors

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17714559.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


26. Jang M, Min SH, Park JK, Tlachac EJ: Hydrous ferric oxide incorporated diatomite for remediation of arsenic contaminated groundwater. Environ Sci Technol; 2007 May 1;41(9):3322-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Based on these proportions of arsenic species and the initial As-to-Fe molar ratio (0.15 molAs mole(-1)), batch kinetic tests revealed that the sorption density (0.076 molAs molFe(-1)) for Fe (25%)-diatomite seems to be less than the expected value (0.086 molAs molFe(-1) calculated from the sorption density data reported by Lafferty and Loeppert (Environ. Sci. Technol.

  • MedlinePlus Health Information. consumer health - Arsenic.
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • Hazardous Substances Data Bank. ARSENIC, ELEMENTAL .
  • Hazardous Substances Data Bank. CARBON .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17539544.001).
  • [ISSN] 0013-936X
  • [Journal-full-title] Environmental science & technology
  • [ISO-abbreviation] Environ. Sci. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Humic Substances; 0 / Water Pollutants, Chemical; 61790-53-2 / Diatomaceous Earth; 68855-54-9 / diatomite; 7440-44-0 / Carbon; E1UOL152H7 / Iron; N712M78A8G / Arsenic
  •  go-up   go-down


27. Smith JH, Padnick-Silver L, Newlin A, Rhodes K, Rubinstein WS: Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Ophthalmology; 2007 Apr;114(4):774-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
  • PURPOSE: To evaluate a kindred with familial uveal and cutaneous melanoma and to identify potential genetic and environmental factors that may predispose individuals to develop uveal melanoma.
  • METHODS: Evaluation of a large sibship via family history, complete eye and skin examinations, environmental risk factor questionnaire, and genetic testing, as well as a MEDLINE search of familial uveal melanoma kindreds.
  • MAIN OUTCOME MEASURES: Cutaneous and ocular nevi, benign and malignant neoplasms of skin and other sites, brief skin cancer risk assessment tool risk classification for cutaneous melanoma, DNA sequencing of p16INK4a and p14ARF genes, and citations on familial uveal melanoma.
  • RESULTS: The proband and his mother had uveal melanoma, 3 cutaneous melanomas occurred among 2 siblings, and 2 other siblings had basal cell carcinomas.
  • No germline mutations were detected in the melanoma-associated tumor suppressor genes p16INK4a and p14ARF.
  • Seven out of 10 siblings had a history of cutaneous and/or ocular nevi.
  • Of the 3 subjects without nevi, 2 had histories of eye or skin malignancies (1 uveal melanoma, 1 basal cell carcinoma).
  • Three of the 10 siblings had relevant ocular findings (2 choroidal nevi, 1 uveal melanoma).
  • This family, combined with the 91 previously reported familial uveal melanoma kindreds, brings to 92 the total number thus far recorded.
  • CONCLUSIONS: Our results strengthen the association between uveal melanoma, atypical nevi, and cutaneous melanoma.
  • This relationship supports the recommendation that individuals with a personal or family history of uveal melanoma, particularly in combination with atypical nevi, should be regularly screened for uveal and cutaneous melanoma.
  • [MeSH-major] Carcinoma, Basal Cell / genetics. Melanoma / genetics. Nevus, Pigmented / genetics. Skin Neoplasms / genetics. Uveal Neoplasms / genetics
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cyclin-Dependent Kinase Inhibitor p16 / genetics. DNA, Neoplasm / analysis. Female. Humans. Male. Middle Aged. Pedigree. Risk Factors. Sequence Analysis, DNA. Surveys and Questionnaires. Tumor Suppressor Protein p14ARF / genetics


28. Hori H, Nagaoka Y, Yamamoto A, Sano T, Yamashita N, Taniyasu S, Kutsuna S, Osaka I, Arakawa R: Efficient decomposition of environmentally persistent perfluorooctanesulfonate and related fluorochemicals using zerovalent iron in subcritical water. Environ Sci Technol; 2006 Feb 1;40(3):1049-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Use of iron led to the most efficient PFOS decomposition: When iron powder was added to an aqueous solution of PFOS (93-372 microM) and the mixture was heated at 350 degrees C for 6 h, PFOS concentration in the reaction solution fell below 2.2 microM (detection limit of HPLC with conductometric detection), with formation of F-ions with yields [i.e., (moles of F- formed)/(moles of fluorine content in initial PFOS) x 100] of 46.2-51.4% and without any formation of perfluorocarboxylic acids.
  • A small amount of CHF3 was detected in the gas phase with a yield [i.e., (moles of CHF3)/(moles of carbon content in initial PFOS) x 100] of 0.7%, after the reaction of PFOS (372 microM) with iron at 350 degree C for 6 h.

  • MedlinePlus Health Information. consumer health - Iron.
  • Hazardous Substances Data Bank. Perfluorooctane sulfonic acid .
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • Hazardous Substances Data Bank. Water .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16509356.001).
  • [ISSN] 0013-936X
  • [Journal-full-title] Environmental science & technology
  • [ISO-abbreviation] Environ. Sci. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Alkanesulfonic Acids; 0 / Environmental Pollutants; 0 / Fluorocarbons; 059QF0KO0R / Water; 1763-23-1 / perfluorooctane sulfonic acid; E1UOL152H7 / Iron
  •  go-up   go-down


29. Rahman MM, Bhattacharya P: An integrated and interactive decision support system for automated melanoma recognition of dermoscopic images. Comput Med Imaging Graph; 2010 Sep;34(6):479-86
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An integrated and interactive decision support system for automated melanoma recognition of dermoscopic images.
  • This paper presents an integrated and interactive decision support system for the automated melanoma recognition of the dermoscopic images based on image retrieval by content and multiple expert fusion.
  • In this context, the ultimate aim is to support the decision making by retrieving and displaying the relevant past cases as well as predicting the image categories (e.g., melanoma, benign and dysplastic nevi) by combining outputs from different classifiers.
  • However, the most challenging aspect in this domain is to detect the lesion from the healthy background skin and extract the lesion-specific local image features.
  • [MeSH-major] Decision Making, Computer-Assisted. Melanoma / diagnosis

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19942406.001).
  • [ISSN] 1879-0771
  • [Journal-full-title] Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
  • [ISO-abbreviation] Comput Med Imaging Graph
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Grichnik JM: Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol; 2008 Oct;128(10):2365-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanoma, nevogenesis, and stem cell biology.
  • A model cancer for the study of the oncologic process is melanoma.
  • The developmental biology of melanocytes is relatively well understood, the cells pigment as they differentiate making them easy to identify, and benign and malignant tumors develop on the skin surface allowing direct observation of growth features, early detection, and removal.
  • The TSC model is still evolving, but the existence of TSCs has significant ramifications for tumor development, diagnosis, prognosis, and treatment of melanoma and other cancers.
  • [MeSH-major] Melanoma / etiology. Melanoma / pathology. Nevus / etiology. Nevus / pathology. Skin Neoplasms / etiology. Skin Neoplasms / pathology. Stem Cells / pathology


31. Alés-Fernández M, Ríos-Martín JJ, Camacho-Martínez FM: Localized argyria secondary to acupuncture mimicking blue nevus. J Drugs Dermatol; 2010 Aug;9(8):1019-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Localized argyria secondary to acupuncture mimicking blue nevus.
  • The lesions often are clinically indistinguishable from blue nevi and metastatic melanoma.
  • [MeSH-major] Acupuncture Therapy / adverse effects. Argyria / etiology. Nevus, Blue / diagnosis

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Acupuncture.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20684156.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Burns JM, Craig PS, Shaw TJ, Ferry JL: Multivariate examination of Fe(II)/Fe(III) cycling and consequent hydroxyl radical generation. Environ Sci Technol; 2010 Oct 1;44(19):7226-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Through the range of experimental conditions of this design, the ratio of the number of moles of HO• produced to the number of moles of Fe(II) consumed varied from 3 to 750, corresponding to approximately 10 to 2200 Fe(II)/Fe(III) cycles, respectively.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20469853.001).
  • [ISSN] 1520-5851
  • [Journal-full-title] Environmental science & technology
  • [ISO-abbreviation] Environ. Sci. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ferric Compounds; 0 / Ferrous Compounds; 0 / Free Radical Scavengers; 3352-57-6 / Hydroxyl Radical
  •  go-up   go-down


33. Hata S, Hamada J, Maeda K, Murai T, Tada M, Furukawa H, Tsutsumida A, Saito A, Yamamoto Y, Moriuchi T: PAX4 has the potential to function as a tumor suppressor in human melanoma. Int J Oncol; 2008 Nov;33(5):1065-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PAX4 has the potential to function as a tumor suppressor in human melanoma.
  • In this study, we first quantified expression of 9 PAX genes in human nevus pigmentosus tissues, melanoma tissues and melanoma cell lines by the real-time reverse transcription-PCR method.
  • As a result, we found that the expression levels of PAX4 and PAX9 were extremely low in melanoma tissues and cell lines compared to nevus pigmentosus tissues.
  • We then established melanoma cells overexpressing PAX4 and examined roles of PAX4 in cell growth.
  • PAX4-overexpression reduced in vitro cell growth of human melanoma C8161 and MeWo cells.
  • Furthermore, treatment of C8161 and MeWo cells with 5-azacytidine, a DNA demethylating agent, induced the expression of PAX4, suggesting that DNA methylation repressed the PAX4 gene expression in human melanoma.
  • [MeSH-major] Homeodomain Proteins / metabolism. Melanoma / metabolism. Nevus, Pigmented / metabolism. Paired Box Transcription Factors / metabolism. Skin Neoplasms / metabolism. Tumor Suppressor Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. AZACITIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18949370.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Enzyme Inhibitors; 0 / Homeodomain Proteins; 0 / PAX4 protein, human; 0 / Paired Box Transcription Factors; 0 / RNA, Messenger; 0 / Tumor Suppressor Proteins; M801H13NRU / Azacitidine
  •  go-up   go-down


34. Namani T, Deamer DW: Stability of model membranes in extreme environments. Orig Life Evol Biosph; 2008 Aug;38(4):329-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Vesicles formed by mixtures of decylamine and decanoic acid (1:1 mole ratio) are relatively permeable to pyranine, a fluorescent anionic dye, but permeability could be reduced by adding 2 mol% of a polycyclic aromatic hydrocarbon such as pyrene.
  • For instance, 1:1 mole ratio mixtures of dodecylamine and dodecanoic acid were able to retain pyranine dye during and following gel filtration.

  • Hazardous Substances Data Bank. DODECYLAMINE .
  • Hazardous Substances Data Bank. DODECANOIC ACID .
  • Hazardous Substances Data Bank. IRON, ELEMENTAL .
  • Hazardous Substances Data Bank. MAGNESIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biochemistry. 1986 May 20;25(10):2804-12 [3718922.001]
  • [Cites] Nature. 1974 Nov 1;252(5478):47-9 [4427679.001]
  • [Cites] Orig Life Evol Biosph. 2007 Oct;37(4-5):439-44 [17610045.001]
  • [Cites] Orig Life Evol Biosph. 1999 Mar;29(2):153-66 [10227201.001]
  • [Cites] Orig Life Evol Biosph. 2005 Aug;35(4):323-32 [16228646.001]
  • [Cites] Orig Life Evol Biosph. 2007 Jun;37(3):267-85 [17361322.001]
  • [Cites] Naturwissenschaften. 2006 Jan;93(1):1-13 [16292523.001]
  • [Cites] Orig Life Evol Biosph. 1989;19(1):21-38 [2748144.001]
  • [Cites] Science. 2004 Sep 3;305(5689):1474-6 [15353806.001]
  • [Cites] J Mol Evol. 1999 Jun;48(6):631-7 [10229566.001]
  • [Cites] Orig Life Evol Biosph. 2002 Aug;32(4):311-32 [12458736.001]
  • [Cites] Biochemistry. 1988 Mar 22;27(6):1881-8 [3378036.001]
  • [Cites] Orig Life Evol Biosph. 2001 Feb-Apr;31(1-2):103-18 [11296515.001]
  • [Cites] Chem Biol. 1995 Oct;2(10):677-82 [9383474.001]
  • [Cites] Biochemistry. 1978 Sep 5;17(18):3759-68 [698196.001]
  • [Cites] Langmuir. 2005 Jul 5;21(14):6210-9 [15982022.001]
  • [Cites] Astrobiology. 2002 Summer;2(2):139-52 [12469365.001]
  • [Cites] Nature. 1973 May 25;243(5404):232-4 [4706295.001]
  • [Cites] Orig Life Evol Biosph. 1986;17(1):3-25 [3796965.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Feb;91:1248-50 [11539550.001]
  • [Cites] Methods Enzymol. 2003;372:133-51 [14610811.001]
  • [Cites] Artif Life. 2004 Summer;10(3):297-308 [15245629.001]
  • [Cites] Microbiol Rev. 1988 Dec;52(4):452-84 [3070320.001]
  • [Cites] Biochim Biophys Acta. 2002 Feb 10;1559(1):1-9 [11825583.001]
  • [Cites] J Am Chem Soc. 2005 Sep 28;127(38):13213-9 [16173749.001]
  • [Cites] Biophys J. 2004 Aug;87(2):988-98 [15298905.001]
  • [Cites] Science. 2003 Oct 24;302(5645):618-22 [14576428.001]
  • (PMID = 18560991.001).
  • [ISSN] 0169-6149
  • [Journal-full-title] Origins of life and evolution of the biosphere : the journal of the International Society for the Study of the Origin of Life
  • [ISO-abbreviation] Orig Life Evol Biosph
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Amines; 0 / Cations; 0 / Fatty Acids; 0 / Fluorescent Dyes; 0 / Lauric Acids; 1160N9NU9U / lauric acid; E1UOL152H7 / Iron; I38ZP9992A / Magnesium; SY7Q814VUP / Calcium; YWY9OD6A2K / dodecylamine
  •  go-up   go-down


35. Samaratunga SS, Nishimoto J, Tabata M: Toluene/ter-butanol mixed solvent for the selective extraction of Cr(VI) from divalent heavy metals. Anal Sci; 2005 Sep;21(9):1073-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chromium(VI) was selectively extracted as a solvated ion-pair of [ter-BuOH2+ x CrO3Cl-] at ter-BuOH mole fractions of between 0.1 and 0.6 (9.0-57.2% in volume).
  • Divalent metals were extracted at ter-BuOH mole fraction over 0.6 with extraction percents of Co (< 20%), Cu (< 15%), Ni (< 10%) and Zn (< 20%).

  • Hazardous Substances Data Bank. CADMIUM COMPOUNDS .
  • Hazardous Substances Data Bank. CALCIUM CHLORIDE .
  • Hazardous Substances Data Bank. TOLUENE .
  • Hazardous Substances Data Bank. NICKEL, ELEMENTAL .
  • Hazardous Substances Data Bank. CHROMIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. COBALT, ELEMENTAL .
  • Hazardous Substances Data Bank. COPPER, ELEMENTAL .
  • Hazardous Substances Data Bank. ZINC, ELEMENTAL .
  • Hazardous Substances Data Bank. T-BUTYL ALCOHOL .
  • Hazardous Substances Data Bank. Water .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16363476.001).
  • [ISSN] 0910-6340
  • [Journal-full-title] Analytical sciences : the international journal of the Japan Society for Analytical Chemistry
  • [ISO-abbreviation] Anal Sci
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Cadmium Compounds; 0 / Carcinogens, Environmental; 0 / Cations, Divalent; 0 / Saline Solution, Hypertonic; 0 / Solutions; 0 / Solvents; 059QF0KO0R / Water; 0R0008Q3JB / Chromium; 18540-29-9 / chromium hexavalent ion; 3FPU23BG52 / Toluene; 3G0H8C9362 / Cobalt; 789U1901C5 / Copper; 7OV03QG267 / Nickel; J41CSQ7QDS / Zinc; M4I0D6VV5M / Calcium Chloride; MD83SFE959 / tert-Butyl Alcohol
  •  go-up   go-down


36. Martinez-Garcia JC, Tamarit JL, Capaccioli S, Barrio M, Veglio N, Pardo LC: Alpha-relaxation dynamics of orientanionally disordered mixed crystals composed of Cl-adamantane and CN-adamantane. J Chem Phys; 2010 Apr 28;132(16):164516
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The characteristic relaxation times are analyzed as a function of temperature and mole fraction.
  • By setting a common temporal origin ("isochronal origin") at tau(T(g)) = 100 s for each mole fraction, it emerges that the substitution of ClA molecules by those of CNA (diminution of X) gives rise to a slow down in the dynamics, despite that the molecular volume of ClA molecules are smaller than those of CNA.
  • It is also shown that the heterogeneities produced by the concentration fluctuations due to the chemical disorder are the main contribution to the non-exponential character of the alpha-relaxation peaks.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20441297.001).
  • [ISSN] 1089-7690
  • [Journal-full-title] The Journal of chemical physics
  • [ISO-abbreviation] J Chem Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Hoskins C, Ouaissi M, Lima SC, Cheng WP, Loureirio I, Mas E, Lombardo D, Cordeiro-da-Silva A, Ouaissi A, Kong Thoo Lin P: In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer. Pharm Res; 2010 Dec;27(12):2694-703
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To evaluate the in vitro and in vivo pancreatic anticancer activity of a nano-sized formulation based on novel polyallylamine grafted with 5% mole cholesteryl pendant groups (CH(5)-PAA).

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Biomater. 2009 Mar;5(3):817-31 [19010748.001]
  • [Cites] Gastroenterology. 2005 May;128(6):1642-54 [15887156.001]
  • [Cites] Minerva Chir. 2009 Oct;64(5):489-500 [19859039.001]
  • [Cites] J Dig Dis. 2008 Feb;9(1):1-7 [18251787.001]
  • [Cites] Semin Oncol. 2007 Aug;34(4):347-53 [17674963.001]
  • [Cites] J Am Coll Surg. 2005 Sep;201(3):359-65 [16125068.001]
  • [Cites] Int J Oncol. 2004 Dec;25(6):1509-19 [15547685.001]
  • [Cites] CA Cancer J Clin. 2002 Jan-Feb;52(1):23-47 [11814064.001]
  • [Cites] Eur J Biochem. 1998 Feb 15;252(1):1-15 [9523706.001]
  • [Cites] Jpn J Clin Oncol. 2004 May;34(5):238-44 [15231857.001]
  • [Cites] Bioconjug Chem. 1999 Sep-Oct;10(5):877-83 [10502356.001]
  • [Cites] Cancer Biol Ther. 2008 Apr;7(4):523-31 [18296916.001]
  • [Cites] Curr Med Chem Anticancer Agents. 2001 Nov;1(3):237-55 [12678756.001]
  • [Cites] Bioorg Med Chem. 2007 Jan 1;15(1):541-5 [17010616.001]
  • [Cites] Mol Cancer Ther. 2005 Aug;4(8):1222-30 [16093438.001]
  • [Cites] Biomacromolecules. 2006 May;7(5):1509-20 [16677033.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Oct 6;348(4):1245-53 [16904634.001]
  • [Cites] Drugs. 2003;63(6):577-96 [12656655.001]
  • [Cites] Pharmacol Ther. 2006 Dec;112(3):630-48 [16815554.001]
  • [Cites] Biophys J. 1999 Jan;76(1 Pt 1):469-77 [9876159.001]
  • [Cites] Biochem Pharmacol. 2005 Jan 1;69(1):19-27 [15588710.001]
  • [Cites] Ann Oncol. 2004 Mar;15(3):474-7 [14998851.001]
  • [Cites] Eur J Pharm Biopharm. 2007 Mar;65(3):259-69 [17196803.001]
  • [Cites] Biochim Biophys Acta. 2007 Jul;1773(7):1095-106 [17555830.001]
  • [Cites] J Immunol Methods. 1991 Jun 3;139(2):271-9 [1710634.001]
  • [Cites] ChemMedChem. 2010 Jan;5(1):140-7 [19937668.001]
  • [Cites] Chem Biol Interact. 2009 Jan 15;177(1):1-6 [18983836.001]
  • [Cites] Biomaterials. 2010 May;31(14):4194-203 [20163854.001]
  • [Cites] J Control Release. 2008 Apr 21;127(2):121-30 [18304673.001]
  • [Cites] Biochem Soc Trans. 2003 Apr;31(2):407-10 [12653648.001]
  • [Cites] J Control Release. 2008 May 22;128(1):23-31 [18374444.001]
  • [Cites] Oncologist. 2008 Mar;13(3):289-98 [18378539.001]
  • [Cites] Bioorg Med Chem Lett. 2000 Jul 17;10(14):1609-12 [10915063.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2403-13 [9196156.001]
  • (PMID = 20872054.001).
  • [ISSN] 1573-904X
  • [Journal-full-title] Pharmaceutical research
  • [ISO-abbreviation] Pharm. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Naphthalimides; 0 / Polymers; 0 / bisnaphthalimidopropyldiaaminooctane
  •  go-up   go-down


38. Nie L, Zhu J, Gratton MA, Liao A, Mu KJ, Nonner W, Richardson GP, Yamoah EN: Molecular identity and functional properties of a novel T-type Ca2+ channel cloned from the sensory epithelia of the mouse inner ear. J Neurophysiol; 2008 Oct;100(4):2287-99
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, unlike most multiion channels, the T-type channel does not exhibit the anomalous mole fraction effect, possibly reflecting comparable permeation properties of divalent cations.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • Xenbase. Xenbase .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hear Res. 1991 Feb;51(2):279-91 [2032962.001]
  • [Cites] Biophys J. 2000 Mar;78(3):1240-54 [10692313.001]
  • [Cites] J Neurophysiol. 1993 Jul;70(1):158-66 [8395572.001]
  • [Cites] Biophys J. 1994 Jun;66(6):1833-43 [8075321.001]
  • [Cites] Biophys J. 1995 Apr;68(4):1323-36 [7787021.001]
  • [Cites] J Gen Physiol. 1995 Apr;105(4):441-62 [7608653.001]
  • [Cites] Neurosci Lett. 1999 Oct 29;274(3):143-6 [10548410.001]
  • [Cites] J Physiol. 1988 Jan;395:233-53 [2457676.001]
  • [Cites] J Biol Chem. 2000 Mar 3;275(9):6090-100 [10692398.001]
  • [Cites] Cell. 2000 Jul 7;102(1):89-97 [10929716.001]
  • [Cites] Brain Res. 2008 Mar 27;1201:68-77 [18294617.001]
  • [Cites] J Neurophysiol. 2000 Dec;84(6):2975-83 [11110825.001]
  • [Cites] Biophys J. 2001 Mar;80(3):1238-50 [11222288.001]
  • [Cites] J Physiol. 2001 Aug 1;534(Pt 3):669-89 [11483699.001]
  • [Cites] J Neurosci. 2001 Aug 15;21(16):6170-80 [11487640.001]
  • [Cites] J Gen Physiol. 1967 Jan;50(3):583-601 [11526848.001]
  • [Cites] J Physiol. 2002 Feb 1;538(Pt 3):729-45 [11826161.001]
  • [Cites] J Physiol. 2002 Apr 1;540(Pt 1):3-14 [11927664.001]
  • [Cites] J Neurosci. 2002 Aug 15;22(16):6856-62 [12177183.001]
  • [Cites] J Neurosci. 2002 Dec 1;22(23):10399-407 [12451139.001]
  • [Cites] Physiol Rev. 2003 Jan;83(1):117-61 [12506128.001]
  • [Cites] J Physiol. 1988 Jun;400:237-74 [2458454.001]
  • [Cites] Neuroscience. 1990;38(1):39-45 [2255399.001]
  • [Cites] J Physiol. 1990 Oct;429:553-68 [1703574.001]
  • [Cites] Hear Res. 1995 Jul;87(1-2):62-8 [8567444.001]
  • [Cites] Annu Rev Physiol. 1996;58:329-48 [8815798.001]
  • [Cites] J Physiol. 1996 Oct 1;496 ( Pt 1):59-68 [8910196.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14883-8 [9405708.001]
  • [Cites] Neuropharmacology. 1998 Jun;37(6):701-8 [9707283.001]
  • [Cites] Eur J Neurosci. 1998 Feb;10(2):545-52 [9749717.001]
  • [Cites] J Bioenerg Biomembr. 1998 Aug;30(4):313-8 [9758328.001]
  • [Cites] Endocrinology. 1999 Mar;140(3):1200-4 [10067844.001]
  • [Cites] J Neurosci. 1999 Mar 15;19(6):1895-911 [10066243.001]
  • [Cites] Neuroscience. 1999 May;90(2):383-8 [10215143.001]
  • [Cites] J Biol Chem. 1999 May 28;274(22):15694-700 [10336467.001]
  • [Cites] J Physiol. 1999 Aug 15;519 Pt 1:35-45 [10432337.001]
  • [Cites] J Neurophysiol. 2004 Dec;92(6):3399-407 [15254077.001]
  • [Cites] J Neurobiol. 2005 Feb 15;62(3):352-60 [15514988.001]
  • [Cites] Circ Res. 2005 Apr 29;96(8):864-72 [15774856.001]
  • [Cites] Drug Discov Today. 2005 Oct 1;10(19):1269-82 [16214671.001]
  • [Cites] Chest. 2005 Dec;128(6 Suppl):581S-582S [16373845.001]
  • [Cites] Proteins. 2006 Aug 1;64(2):320-42 [16671074.001]
  • [Cites] Pharmacology. 2006;78(1):11-20 [16899990.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19108-13 [18025474.001]
  • [Cites] Biophys J. 2003 May;84(5):3457-69 [12719271.001]
  • [Cites] Eur J Neurosci. 2003 May;17(9):1802-10 [12752779.001]
  • [Cites] J Physiol. 2003 Jun 15;549(Pt 3):697-717 [12740421.001]
  • [Cites] J Neurophysiol. 2003 Jul;90(1):155-64 [12843307.001]
  • [Cites] J Physiol. 2003 Dec 15;553(Pt 3):747-58 [14514878.001]
  • [Cites] Curr Top Dev Biol. 2003;57:389-448 [14674488.001]
  • [Cites] J Bioenerg Biomembr. 2003 Dec;35(6):533-75 [15000520.001]
  • [Cites] J Neurophysiol. 2004 Apr;91(4):1536-44 [14657188.001]
  • [Cites] J Assoc Res Otolaryngol. 2004 Jun;5(2):215-26 [15357422.001]
  • [Cites] J Physiol. 1981 Jun;315:569-84 [7310722.001]
  • [Cites] J Physiol. 1982 Oct;331:231-52 [6296367.001]
  • [Cites] Science. 1987 Feb 6;235(4789):680-2 [2433765.001]
  • [Cites] J Physiol. 1987 Apr;385:207-42 [2443666.001]
  • [Cites] Brain Res Dev Brain Res. 1991 Nov 19;63(1-2):53-61 [1790598.001]
  • (PMID = 18753322.001).
  • [ISSN] 0022-3077
  • [Journal-full-title] Journal of neurophysiology
  • [ISO-abbreviation] J. Neurophysiol.
  • [Language] ENG
  • [Grant] United States / NIDCD NIH HHS / DC / DC-003826; United States / NIDCD NIH HHS / DC / DC-006442
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cacna1g protein, mouse; 0 / Calcium Channels, T-Type; 0 / DNA, Complementary
  • [Other-IDs] NLM/ PMC2576198
  •  go-up   go-down


39. Babushkina OB, Ekres S, Nauer GE: Raman spectroscopy of the mixtures (x)1-butyl-1-methylpyrrolidinium chloride-(1 - x)TaCl5 in solid and molten states. J Phys Chem A; 2008 Sep 11;112(36):8288-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The formation of oxochloride species of tantalum(V) was investigated in mixtures of Pyr14Cl-TaCl5-Na2O (x = 0.65) at various O/Ta mole ratios, and the formation of the oligomeric species with Ta-O-Ta bridging bonds was determined.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18707058.001).
  • [ISSN] 1520-5215
  • [Journal-full-title] The journal of physical chemistry. A
  • [ISO-abbreviation] J Phys Chem A
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


40. Lan BY, Nigmatullin R, Li Puma G: Ozonation kinetics of cork-processing water in a bubble column reactor. Water Res; 2008 May;42(10-11):2473-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The ozonation of cork-processing water in the bubble column was analysed in terms of a mole balance coupled with ozonation kinetics modelled by the two-film theory of mass transfer and chemical reaction.

  • MedlinePlus Health Information. consumer health - Ozone.
  • Hazardous Substances Data Bank. OZONE .
  • Hazardous Substances Data Bank. OXYGEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18342905.001).
  • [ISSN] 0043-1354
  • [Journal-full-title] Water research
  • [ISO-abbreviation] Water Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Industrial Waste; 66H7ZZK23N / Ozone; S88TT14065 / Oxygen
  •  go-up   go-down


41. Kamitakahara M, Kawashita M, Miyata N, Kokubo T, Nakamura T: Preparation of bioactive flexible poly(tetramethylene oxide) (PTMO)-CaO-Ta2O5 hybrids. J Mater Sci Mater Med; 2007 Jun;18(6):1117-24
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the system PTMO-CaO-Ta2O5, the Si-PTMO/Ta(OEt)5 weight ratio was 40/60 and CaCl2/Ta(OEt)5 mole ratios were 0.05, 0.10 and 0.15 (hybrids PT40Ca5, PT40Ca10 and PT40Ca15, respectively).

  • Hazardous Substances Data Bank. CALCIUM COMPOUNDS .
  • Hazardous Substances Data Bank. CALCIUM OXIDE .
  • Hazardous Substances Data Bank. TANTALUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biomed Mater Res. 1990 Jun;24(6):721-34 [2361964.001]
  • [Cites] J Biomed Mater Res A. 2003 Jan 1;64(1):164-70 [12483709.001]
  • [Cites] Biomaterials. 2002 Jul;23(14):3033-40 [12069346.001]
  • [Cites] J Mater Sci Mater Med. 2003 Dec;14(12):1067-72 [15348499.001]
  • [Cites] J Biomed Mater Res. 2000 Sep 15;51(4):605-11 [10880108.001]
  • [Cites] J Mater Sci Mater Med. 1997 Mar;8(3):157-61 [15348769.001]
  • [Cites] Biomaterials. 1981 Jul;2(3):185-6 [6268209.001]
  • [Cites] J Bioeng. 1977 Jan;1(2):79-92 [355244.001]
  • [Cites] J Mater Sci Mater Med. 2002 Nov;13(11):1015-20 [15348170.001]
  • [Cites] J Mater Sci Mater Med. 2001 Jun;12(6):515-22 [15348267.001]
  • [Cites] Biomaterials. 2003 Apr;24(8):1357-63 [12527277.001]
  • [Cites] Biomaterials. 2004 Jan;25(1):1-7 [14580903.001]
  • [Cites] J Biomed Mater Res. 1994 Jan;28(1):7-15 [8126031.001]
  • [Cites] J Appl Biomater. 1993 Fall;4(3):221-9 [10146306.001]
  • [Cites] Biomaterials. 1991 Mar;12(2):155-63 [1878450.001]
  • [Cites] Biomaterials. 1999 Jun;20(12):1127-32 [10382828.001]
  • (PMID = 17268865.001).
  • [ISSN] 0957-4530
  • [Journal-full-title] Journal of materials science. Materials in medicine
  • [ISO-abbreviation] J Mater Sci Mater Med
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Apatites; 0 / Biocompatible Materials; 0 / Calcium Compounds; 0 / Gels; 0 / Oxides; 0 / Solutions; 0 / polytetramethyloxide; 59763-75-6 / tantalum oxide; 6424HBN274 / Tantalum; C7X2M0VVNH / lime
  •  go-up   go-down


42. Schechter I, Ziv E: Inhibitors can activate proteases to catalyze the synthesis and hydrolysis of peptides. Biochemistry; 2006 Dec 12;45(49):14567-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One mole of the inhibitor could catalyze rapid hydrolysis of at least 53 mol of substrate.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17144650.001).
  • [ISSN] 0006-2960
  • [Journal-full-title] Biochemistry
  • [ISO-abbreviation] Biochemistry
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dipeptides; 0 / Peptides; 0 / Protease Inhibitors; EC 3.4.- / Peptide Hydrolases; EC 3.4.21.4 / Trypsin; EC 3.4.22.2 / Papain
  •  go-up   go-down


43. Tolocka MP, Heaton KJ, Dreyfus MA, Wang S, Zordan CA, Saul TD, Johnston MV: Chemistry of particle inception and growth during alpha-pinene ozonolysis. Environ Sci Technol; 2006 Mar 15;40(6):1843-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The carbon-to-oxygen mole ratios of suspected nucleating agents are in the range of 2.25-4.0, while the measured ratios are from 1.9 for 9 nm particles to 2.5 and 2.7 for 30 and 50 nm particles, respectively.

  • MedlinePlus Health Information. consumer health - Ozone.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. OZONE .
  • Hazardous Substances Data Bank. CARBON .
  • Hazardous Substances Data Bank. Water .
  • Hazardous Substances Data Bank. OXYGEN .
  • Hazardous Substances Data Bank. ALPHA-PINENE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16570606.001).
  • [ISSN] 0013-936X
  • [Journal-full-title] Environmental science & technology
  • [ISO-abbreviation] Environ. Sci. Technol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aerosols; 0 / Air Pollutants; 0 / Monoterpenes; 0 / Oxidants, Photochemical; 059QF0KO0R / Water; 66H7ZZK23N / Ozone; 7440-44-0 / Carbon; JPF3YI7O34 / alpha-pinene; S88TT14065 / Oxygen
  •  go-up   go-down


44. Sizgek GD, Sizgek E, Griffith CS, Luca V: Mesoporous zirconium titanium oxides. Part 2: Synthesis, porosity, and adsorption properties of beads. Langmuir; 2008 Nov 4;24(21):12323-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mesoporous zirconium titanium mixed-oxide beads having disordered wormhole textures and mole fractions of Zr (x) ranging from x=0.25 to 0.67 have been prepared.
  • The specific surface areas of the beads were linked to the Zr mole fraction in the precursor solution and were generally greater than 350 m2/g for x=0.5.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18828618.001).
  • [ISSN] 0743-7463
  • [Journal-full-title] Langmuir : the ACS journal of surfaces and colloids
  • [ISO-abbreviation] Langmuir
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


45. Thomas L, Dalle S: Dermoscopy provides useful information for the management of melanonychia striata. Dermatol Ther; 2007 Jan-Feb;20(1):3-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the case of brown longitudinal pigmentation with parallel regular lines, the diagnosis of nail apparatus melanocytic nevus could be made.
  • On the other hand, the presence of a brown pigmentation overlaid by longitudinal lines irregular in their thickness, spacing, color, or parallelism is highly in favor of a melanoma.
  • [MeSH-minor] Dermoscopy. Diagnosis, Differential. Humans. Melanoma / diagnosis. Melanoma / pathology. Skin Neoplasms / diagnosis. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Nail Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17403255.001).
  • [ISSN] 1396-0296
  • [Journal-full-title] Dermatologic therapy
  • [ISO-abbreviation] Dermatol Ther
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Denmark
  • [Number-of-references] 14
  •  go-up   go-down


46. Reynolds F, Weissleder R, Josephson L: Protamine as an efficient membrane-translocating peptide. Bioconjug Chem; 2005 Sep-Oct;16(5):1240-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Protamine, a mixture of positively charged proteins from salmon roe used in diverse pharmaceutical applications, was reacted with the N-hydroxysuccinimide ester of tetramethylrhodamine to yield tetramethylrhodamine-labeled protamines (Pro(Rh)) containing one mole of fluorochrome per mole of protein.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. FLUORESCEIN .
  • Hazardous Substances Data Bank. D&C Yellow No. 8 .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16173804.001).
  • [ISSN] 1043-1802
  • [Journal-full-title] Bioconjugate chemistry
  • [ISO-abbreviation] Bioconjug. Chem.
  • [Language] eng
  • [Grant] United States / NIBIB NIH HHS / EB / R01 EB004626; United States / NIBIB NIH HHS / EB / R01-EB00662
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fish Proteins; 0 / Gene Products, tat; 0 / Peptide Fragments; 0 / Protamines; 0 / Rhodamines; TPY09G7XIR / Fluorescein
  •  go-up   go-down


47. Takeda H, Ikenaga S, Kaneko T, Nakajima K, Harada K, Hanada K, Sawamura D: Proliferating trichilemmal tumor developing in nevus sebaceous. Eur J Dermatol; 2010 Sep-Oct;20(5):664-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proliferating trichilemmal tumor developing in nevus sebaceous.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Nevus, Sebaceous of Jadassohn / pathology. Scalp. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20627855.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] France
  •  go-up   go-down


48. Kacerovska D, Michal M, Kazakov DV: Sebocyte-like melanocytes in desmoplastic blue nevus. Am J Dermatopathol; 2008 Oct;30(5):509-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sebocyte-like melanocytes in desmoplastic blue nevus.
  • [MeSH-major] Melanocytes / pathology. Nevus, Blue / pathology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18806502.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


49. Zubidat AE, Nelson RJ, Haim A: Photoentrainment in blind and sighted rodent species: responses to photophase light with different wavelengths. J Exp Biol; 2010 Dec 15;213(Pt 24):4213-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Social voles (Microtus socialis) and 'blind' mole rats (Spalax ehrenbergi) were exposed to short-wavelength (479 nm) or long-wavelength (697 nm) light at an intensity of 293 μW cm(-2).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • Hazardous Substances Data Bank. EPINEPHRINE .
  • Hazardous Substances Data Bank. MELATONIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21113002.001).
  • [ISSN] 1477-9145
  • [Journal-full-title] The Journal of experimental biology
  • [ISO-abbreviation] J. Exp. Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 2208-40-4 / 6-sulfatoxymelatonin; JL5DK93RCL / Melatonin; WI4X0X7BPJ / Hydrocortisone; YKH834O4BH / Epinephrine
  •  go-up   go-down


50. Jain JP, Kumar N: Self assembly of amphiphilic (PEG)(3)-PLA copolymer as polymersomes: preparation, characterization, and their evaluation as drug carrier. Biomacromolecules; 2010 Apr 12;11(4):1027-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For this, three chains of methoxy-PEG(1100) were directly attached to citric acid by esterification. (Methoxy-PEG(1100))(3)-citrate was then reacted at its hydroxyl terminal with different moles of d,l-lactide by ring-opening polymerization to obtain polymers with five different PEG-to-PLA ratios ranging from 10:90 to 90:10.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20178378.001).
  • [ISSN] 1526-4602
  • [Journal-full-title] Biomacromolecules
  • [ISO-abbreviation] Biomacromolecules
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drug Carriers; 0 / Polymers; 0 / monomethoxypolyethyleneglycol-polylactide block copolymer; 30IQX730WE / Polyethylene Glycols
  •  go-up   go-down


51. Kacerovska D, Sima R, Michal M, Hes O, Roucka P, Zarybnicka M, Hora M, Chudacek Z, Kazakov DV: Carney complex: a clinicopathologic and molecular biological study of a sporadic case, including extracutaneous and cutaneous lesions and a novel mutation of the PRKAR1A gene. J Am Acad Dermatol; 2009 Jul;61(1):80-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Carney complex (CNC) is an autosomal dominant disorder associated with multiple neoplasms.
  • Additionally, a blue nevus, a lipoma, multiple calcifications in both testes, and hypoechogenic areas suspected of being adenomas in the thyroid gland were found.
  • [MeSH-major] Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / genetics. Endocrine Gland Neoplasms / genetics. Heart Neoplasms / genetics. Myxoma / genetics. Pigmentation Disorders / genetics. Skin Neoplasms / genetics

  • Genetic Alliance. consumer health - Carney Complex.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Skin Pigmentation Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19539840.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; 0 / PRKAR1A protein, human
  •  go-up   go-down


52. Domańska U, Pobudkowska A, Pelczarska A, Gierycz P: pKa and solubility of drugs in water, ethanol, and 1-octanol. J Phys Chem B; 2009 Jul 2;113(26):8941-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The equilibrium mole fraction solubilities of six drugs were measured in a range of temperatures from 240 to 340 K in three important solvents for drugs: water, ethanol, and 1-octanol using the dynamic method.

  • MedlinePlus Health Information. consumer health - Medicines.
  • Hazardous Substances Data Bank. 1-OCTANOL .
  • Hazardous Substances Data Bank. ETHANOL .
  • Hazardous Substances Data Bank. Water .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19518053.001).
  • [ISSN] 1520-6106
  • [Journal-full-title] The journal of physical chemistry. B
  • [ISO-abbreviation] J Phys Chem B
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Pharmaceutical Preparations; 0 / Solvents; 059QF0KO0R / Water; 3K9958V90M / Ethanol; NV1779205D / 1-Octanol
  •  go-up   go-down


53. Kim HH, Cannata JM, Liu R, Chang JH, Silverman RH, Shung KK: 20 MHz/40 MHz dual element transducers for high frequency harmonic imaging. IEEE Trans Ultrason Ferroelectr Freq Control; 2008 Dec;55(12):2683-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Images of a posterior segment of an excised pig eye and a choroidal nevus of human eye were obtained both for single element and dual element transducers and compared to demonstrate the advantages of dual element harmonic imaging.

  • MedlinePlus Health Information. consumer health - Ultrasound.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Dec;52(12):2418-22 [16463509.001]
  • [Cites] Ophthalmology. 2004 Jul;111(7):1344-51 [15234135.001]
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 2003 Nov;50(11):1548-57 [14682638.001]
  • [Cites] Ultrasound Med Biol. 2002 Jan;28(1):1-18 [11879947.001]
  • [Cites] J Refract Surg. 2000 Jul-Aug;16(4):414-30 [10939721.001]
  • [Cites] Ultrasonics. 2006 Dec 22;44 Suppl 1:e105-7 [16949117.001]
  • [Cites] IEEE Trans Ultrason Ferroelectr Freq Control. 2006 Oct;53(10):1730-8 [17036782.001]
  • (PMID = 19126492.001).
  • [ISSN] 1525-8955
  • [Journal-full-title] IEEE transactions on ultrasonics, ferroelectrics, and frequency control
  • [ISO-abbreviation] IEEE Trans Ultrason Ferroelectr Freq Control
  • [Language] ENG
  • [Grant] United States / NIBIB NIH HHS / EB / P41 EB002182; United States / NIBIB NIH HHS / EB / P41-EB002182; United States / NIBIB NIH HHS / EB / P41 EB002182-12; United States / NIBIB NIH HHS / EB / EB002182-12; United States / NIBIB NIH HHS / EB / EB00238
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Oxides; 05175J654G / Niobium; 12031-63-9 / lithium niobate
  • [Other-IDs] NLM/ NIHMS130182; NLM/ PMC2717901
  •  go-up   go-down


54. Sabatini K, Mattila JP, Kinnunen PK: Interfacial behavior of cholesterol, ergosterol, and lanosterol in mixtures with DPPC and DMPC. Biophys J; 2008 Sep;95(5):2340-55
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For fluid DMPC matrix, no modulation of the monolayer phase behavior due to the sterols was evident with the exception of lanosterol, for which a pronounced discontinuity between mole fractions of X = 0.3 and X = 0.75 was discernible in the compression isotherms.

  • MedlinePlus Health Information. consumer health - Cholesterol.
  • Hazardous Substances Data Bank. ERGOSTEROL .
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • Hazardous Substances Data Bank. Water .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Biophys J. 1999 Apr;76(4):2142-57 [10096908.001]
  • [Cites] Biophys J. 2007 May 15;92(10):3346-57 [17293396.001]
  • [Cites] Eur Biophys J. 2004 Dec;33(8):732-41 [15221234.001]
  • [Cites] Biophys J. 2005 Mar;88(3):1799-808 [15596499.001]
  • [Cites] Chem Phys Lipids. 2005 Jul;136(1):1-12 [15904906.001]
  • [Cites] Eur Biophys J. 2005 Dec;35(1):79-88 [16205919.001]
  • [Cites] J Biol Chem. 2006 Jan 6;281(1):348-55 [16249181.001]
  • [Cites] Biochemistry. 2006 Jan 31;45(4):1227-33 [16430218.001]
  • [Cites] Biochim Biophys Acta. 2005 Dec 30;1720(1-2):84-91 [16386704.001]
  • [Cites] Biophys J. 2006 Mar 1;90(5):1639-49 [16326903.001]
  • [Cites] Biophys J. 2006 Apr 1;90(7):2368-82 [16399829.001]
  • [Cites] Biophys J. 2006 May 1;90(9):3176-83 [16461392.001]
  • [Cites] Biophys J. 2006 Jun 15;90(12):4428-36 [16565062.001]
  • [Cites] Biophys J. 2006 Nov 1;91(9):3327-40 [16905603.001]
  • [Cites] Biophys J. 2007 Apr 15;92(8):2842-53 [17237193.001]
  • [Cites] Biochemistry. 2000 Feb 8;39(5):843-9 [10653627.001]
  • [Cites] J Biol Chem. 2001 Sep 7;276(36):33540-6 [11432870.001]
  • [Cites] Biophys J. 2002 Mar;82(3):1429-44 [11867458.001]
  • [Cites] Biochemistry. 2002 May 7;41(18):5913-9 [11980495.001]
  • [Cites] Biophys J. 2002 Aug;83(2):1014-25 [12124283.001]
  • [Cites] Biochemistry. 2002 Oct 29;41(43):13078-86 [12390036.001]
  • [Cites] J Lipid Res. 2004 Feb;45(2):347-55 [14594996.001]
  • [Cites] Biophys J. 2004 Mar;86(3):1510-20 [14990478.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jun 11;318(4):920-6 [15147960.001]
  • [Cites] Colloids Surf B Biointerfaces. 2004 Aug 15;37(1-2):21-5 [15450304.001]
  • [Cites] Science. 1965 Oct 1;150(3692):19-28 [5319508.001]
  • [Cites] Biochim Biophys Acta. 1968 Nov 5;163(3):301-13 [5721894.001]
  • [Cites] Lipids. 1974 Aug;9(8):596-612 [4607429.001]
  • [Cites] Biochim Biophys Acta. 1975 Sep 16;406(1):97-107 [1174576.001]
  • [Cites] Biochim Biophys Acta. 1978 Feb 21;507(2):207-18 [626732.001]
  • [Cites] Nature. 1978 Jul 27;274(5669):394-5 [209332.001]
  • [Cites] Biochemistry. 1980 Apr 1;19(7):1462-7 [7388005.001]
  • [Cites] Science. 1982 Apr 2;216(4541):65-7 [7063872.001]
  • [Cites] CRC Crit Rev Biochem. 1983;14(1):47-92 [6340956.001]
  • [Cites] Biochim Biophys Acta. 1985 Dec 9;822(3-4):267-87 [3904832.001]
  • [Cites] Biochim Biophys Acta. 1987 Nov 27;905(1):162-72 [3676307.001]
  • [Cites] Biophys J. 1990 Mar;57(3):405-12 [2306491.001]
  • [Cites] Biophys J. 1992 May;61(5):1176-83 [1600079.001]
  • [Cites] Chem Phys Lipids. 1994 Sep 6;73(1-2):57-79 [8001185.001]
  • [Cites] Biochim Biophys Acta. 1995 Sep 13;1238(2):163-76 [7548131.001]
  • [Cites] J Membr Biol. 1995 Jul;146(1):1-14 [7563032.001]
  • [Cites] Biophys J. 1996 Feb;70(2):868-77 [8789104.001]
  • [Cites] Biophys J. 1997 Jun;72(6):2569-80 [9168032.001]
  • [Cites] Biophys J. 1997 Jul;73(1):267-76 [9199791.001]
  • [Cites] Biophys J. 1998 Nov;75(5):2147-56 [9788908.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5372-7 [17372226.001]
  • [Cites] Curr Opin Struct Biol. 1999 Aug;9(4):438-43 [10449364.001]
  • (PMID = 18515391.001).
  • [ISSN] 1542-0086
  • [Journal-full-title] Biophysical journal
  • [ISO-abbreviation] Biophys. J.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membranes, Artificial; 059QF0KO0R / Water; 1J05Z83K3M / Lanosterol; 2644-64-6 / 1,2-Dipalmitoylphosphatidylcholine; 97C5T2UQ7J / Cholesterol; U86ZGC74V5 / Dimyristoylphosphatidylcholine; Z30RAY509F / Ergosterol
  • [Other-IDs] NLM/ PMC2517046
  •  go-up   go-down


55. Lee CJ, Yang J: alpha-Cyclodextrin-modified infrared sensing system for rapidly determining the enantiomeric composition of chiral compounds. Talanta; 2008 Feb 15;74(5):1104-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A linear relationship between the analytical signals and the mole fraction of the enantiomers was obtained under conditions in which the concentration of the chiral compound was sufficiently low.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18371757.001).
  • [ISSN] 1873-3573
  • [Journal-full-title] Talanta
  • [ISO-abbreviation] Talanta
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Organic Chemicals; 0 / alpha-Cyclodextrins; Z1LH97KTRM / alpha-cyclodextrin
  •  go-up   go-down


56. Drunkenmölle E, Marsch WCh, Lübbe D, Helmbold P: Paratumoral epidermal hyperplasia: a novel prognostic factor in thick primary melanoma of the skin? Am J Dermatopathol; 2005 Dec;27(6):482-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paratumoral epidermal hyperplasia: a novel prognostic factor in thick primary melanoma of the skin?
  • There is a lack of histopathological factors to sub-stratify prognosis in pT3/4 melanoma primaries.
  • In the presented pilot study, the prognostic significance of different clinical and histopathological parameters was studied in thick primary melanoma taking paratumoral epidermal hyperplasia (PTEH) into consideration.
  • Of 1632 melanoma patients in the melanoma register of the Martin Luther University Halle-Wittenberg in the years 1980 to 1987, 16 cases with tumor thickness (TT) of the primary > or = 3 mm, documented metastasis-free follow-up of 10+ years after primary therapy and available histologic sections were compared with an adequate recurrence control group (n = 62) by PTEH and standard prognostic parameters.
  • Of the standard prognostic parameters, TT, sex, location, and lack of nevus association also correlated with metastasis.
  • Occurrence of PTEH might predict a more moderate course of disease in thick melanoma.
  • Thus, it might become an easily determinable and effective tool to sub-stratify prognosis in thick primary melanoma of the skin.
  • [MeSH-major] Epidermis / pathology. Melanoma / pathology. Neoplasm Metastasis / diagnosis. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16314703.001).
  • [ISSN] 0193-1091
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Receptor, Epidermal Growth Factor
  •  go-up   go-down


57. Matsuda N, Katsube K, Mikami S, Katsuki Y, Iseki H, Mukai M, Yamaguchi A, Takano Y, Nakajima T, Nakajima H, Kishi K: E-cadherin expression in the subepithelial nevus cells of the giant congenital nevocellular nevi (GCNN) correlates with their migration ability in vitro. J Dermatol Sci; 2008 Oct;52(1):21-30
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] E-cadherin expression in the subepithelial nevus cells of the giant congenital nevocellular nevi (GCNN) correlates with their migration ability in vitro.
  • BACKGROUND: Giant congenital nevocellular nevi (GCNN) are histologically characterized by the broad distribution of nevus cells in the epidermis and dermis.
  • RESULTS: The nevus cells in the superficial region showed the immunoreactivity of E-cadherin in a membranous pattern, but those in the deep part of dermis had little immunoreactivity.
  • Ultra-structural analysis of the superficial nevus cells revealed that E-cadherin immunodeposits in the fibrillar processes around the cell body in a spotted pattern.
  • This distribution pattern is quite different from that in the adherens junction of skin squamous epithelial cells.
  • Boyden chamber experiments were performed using primary cultures of intradermal nevus cells.
  • CONCLUSIONS: These results indicate that E-cadherin in the nevus cells may affect nevus cell motility rather than intercellular attachment.
  • [MeSH-major] Cadherins / metabolism. Cell Movement. Epidermis / metabolism. Epithelial Cells / metabolism. Nevus, Intradermal / congenital. Nevus, Intradermal / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adult. Child, Preschool. Humans. Infant. Microscopy, Immunoelectron. Skin Neoplasms / congenital. Skin Neoplasms / metabolism. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Giant Congenital Nevi.
  • Genetic Alliance. consumer health - Nevus.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18502615.001).
  • [ISSN] 0923-1811
  • [Journal-full-title] Journal of dermatological science
  • [ISO-abbreviation] J. Dermatol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Cadherins; 0 / beta Catenin
  •  go-up   go-down


58. Bakshi MS, Kaur G: Mixed micelles of series of monomeric and dimeric cationic, zwitterionic, and unequal twin-tail cationic surfactants with sugar surfactants: a fluorescence study. J Colloid Interface Sci; 2005 Sep 15;289(2):551-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Steady state fluorescence measurements have been carried out for binary mixtures of a series of monomeric cationic (MC), zwitterionic (ZI), dimeric cationic (DC), and twin-tail cationic (TC) surfactants with sugar (beta-C8G and beta-C12G) over the whole mole fraction range using pyrene as fluorescence probe.
  • The various micellar parameters, such as micelle mole fraction (X1), regular solution interaction parameter (beta), micropolarity, and mean micelle aggregation number (Nagg), have been determined for all these series of mixtures.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16112236.001).
  • [ISSN] 0021-9797
  • [Journal-full-title] Journal of colloid and interface science
  • [ISO-abbreviation] J Colloid Interface Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. McGowan JW, Smith MK, Ryan M, Hood AF: Proliferative nodules with balloon-cell change in a large congenital melanocytic nevus. J Cutan Pathol; 2006 Mar;33(3):253-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proliferative nodules with balloon-cell change in a large congenital melanocytic nevus.
  • The balloon-cell nevus was first described over 100 years ago.
  • Since then, balloon-cell changes of melanocytes have been noted in numerous tumors, including melanoma, blue nevus, and Spitz nevus.
  • We report a case in which balloon-cell changes were found within proliferative nodules occurring in a large congenital melanocytic nevus.
  • [MeSH-major] Melanocytes / pathology. Nevus, Pigmented / congenital. Nevus, Pigmented / pathology. Skin Neoplasms / congenital. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16466515.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


60. Izumi M, Tang X, Chiu CS, Nagai T, Matsubayashi J, Iwaya K, Umemura S, Tsuboi R, Mukai K: Ten cases of sebaceous carcinoma arising in nevus sebaceus. J Dermatol; 2008 Nov;35(11):704-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ten cases of sebaceous carcinoma arising in nevus sebaceus.
  • Although nevus sebaceus is known to develop various types of secondary neoplasms, it rarely causes carcinoma and only 14 cases of secondary sebaceous carcinoma have been reported.
  • In this study, 10 cases of sebaceous carcinoma arising in nevus sebaceus were collected.
  • Sebaceous carcinoma arising in nevus sebaceous predominantly occurred on the scalp (8/10) of elderly women (mean age, 67.7 years).
  • In two cases there were coexisting benign-looking sebaceous lesions at the periphery of the main cancer nodule, and in these lesions p53 showed low positivity compared with the clearly malignant area.
  • There was co-occurrence of another neoplasm in three cases with trichoblastoma, sebaceoma and syringocystadenoma papilliferum, respectively.
  • All cases were treated by excision of the malignant lesion, with or without inclusion of the nevus sebaceus.
  • With these specific pathological and immunohistochemical findings using adipophilin, perilipin and p53, we have to consider the possibility that there is a tendency to underdiagnose secondary sebaceous carcinomas in nevus sebaceus.
  • These clinicopathological features of sebaceous carcinomas developing in the nevus sebaceus seem to indicate different biological entities from de novo sebaceous carcinoma.
  • [MeSH-major] Carcinoma / secondary. Nevus, Sebaceous of Jadassohn / pathology. Sebaceous Gland Neoplasms / secondary. Skin / pathology


61. Gershtenson PC, Krunic A, Chen H, Konanahalli M, Worobec S: Subungual and periungual congenital blue naevus. Australas J Dermatol; 2009 May;50(2):144-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subungual and periungual congenital blue naevus.
  • Subungual pigmented lesions should raise concern about malignant melanoma.
  • Blue naevus of the nail apparatus is a rare entity, with only ten cases described in the literature.
  • Initial biopsy was consistent with a blue naevus of the cellular type and, given the recent clinical change and periungual extension, complete excision was recommended.
  • Reconstruction was performed with a full-thickness skin graft.
  • We present a case of a congenital subungual and periungual blue naevus of the cellular type and review the literature on this rare presentation of a congenital blue naevus.
  • [MeSH-major] Nails / pathology. Nevus, Blue / congenital. Skin Neoplasms / congenital
  • [MeSH-minor] Female. Humans. Skin Transplantation. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19397572.001).
  • [ISSN] 1440-0960
  • [Journal-full-title] The Australasian journal of dermatology
  • [ISO-abbreviation] Australas. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


62. Piana S, Gelli MC, Grenzi L, Ricci C, Gardini S, Piana S: Multifocal melanoma arising on nevus spilus. Int J Dermatol; 2006 Nov;45(11):1380-1
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multifocal melanoma arising on nevus spilus.
  • [MeSH-major] Lentigo / complications. Melanoma / etiology. Neoplasms, Multiple Primary / etiology. Skin Neoplasms / etiology

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17076737.001).
  • [ISSN] 0011-9059
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


63. Leadbeater NE, Smith RJ, Barnard TM: Using in situ Raman monitoring as a tool for rapid optimisation and scale-up of microwave-promoted organic synthesis: esterification as an example. Org Biomol Chem; 2007 Mar 7;5(5):822-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With conditions in hand, an automated stop-flow apparatus was used to prepare 5.7 moles of product.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17315069.001).
  • [ISSN] 1477-0520
  • [Journal-full-title] Organic & biomolecular chemistry
  • [ISO-abbreviation] Org. Biomol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


64. Demerdjieva Z, Kavaklieva S, Tsankov N: Epidermal nevus syndrome and didymosis aplasticosebacea. Pediatr Dermatol; 2007 Sep-Oct;24(5):514-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidermal nevus syndrome and didymosis aplasticosebacea.
  • The epidermal nevus syndrome is a disease complex consisting of the association of an epidermal nevus with various developmental abnormalities of the skin, eyes, nervous, skeletal, cardiovascular, and urogenital systems.
  • The epidermal nevi are classified according to their predominant component; nevus sebaceus (sebaceous glands), nevus comedonicus (hair follicles), and nevus verrucosus (keratinocytes).
  • We report a neonate who presented with a nevus sebaceus on the scalp and face as well as a coloboma and dermoid on his left eye.
  • Within the sebaceous nevus on the scalp, circumscribed lesions of aplasia cutis congenita were detected, which is consistent with the recently proposed term in the literature didymosis aplasticosebacea.
  • [MeSH-major] Ectodermal Dysplasia / pathology. Hamartoma / pathology. Nevus / pathology


65. Bush JA, Ferguson MW, Mason T, McGrouther DA: Skin tension or skin compression? Small circular wounds are likely to shrink, not gape. J Plast Reconstr Aesthet Surg; 2008;61(5):529-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Skin tension or skin compression? Small circular wounds are likely to shrink, not gape.
  • Br J Plast Surg 1991;44:291-4] Karl Langer suggested that information could be gained about the tension inherent in skin, in all directions, by observing the wound edge retraction that occurred after making circular skin incisions [Langer K.
  • On the anatomy and physiology of the skin II.
  • Skin tension. Br J Plast Surg 1978;31:93-106].
  • Circular wounds may be used to demonstrate the orientation of the dominant axis of 'tension' in the skin but is this always a tensile stress as opposed to a compressive stress?
  • One hundred and seventy-five benign head and neck lesions were excised from 72 volunteers using circular dermal punch biopsies.
  • The directional effects of skin.
  • A bioengineering study of skin with particular reference to Langer's Lines.
  • J Invest Dermatol 1966;46:341-6] of skin has individual components which are under tensional force due to elastic retraction.
  • Wounds smaller than the rhomboidal unit will reduce in area, due to the intact tensional forces in the individual dermal components, giving an appearance of the skin overall being under compression.
  • [MeSH-major] Dermatologic Surgical Procedures. Skin Physiological Phenomena. Wound Healing / physiology
  • [MeSH-minor] Adult. Aged. Biopsy. Cicatrix / physiopathology. Female. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / physiopathology. Head and Neck Neoplasms / surgery. Humans. Male. Middle Aged. Nevus / pathology. Nevus / physiopathology. Nevus / surgery. Skin / pathology. Skin Neoplasms / pathology. Skin Neoplasms / physiopathology. Skin Neoplasms / surgery. Stress, Mechanical

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Plast Reconstr Aesthet Surg. 2009 May;62(5):705-6 [19230813.001]
  • (PMID = 17652049.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  •  go-up   go-down


66. Marques YM, de Lima Mde D, Raitz R, Pinto Ddos S Jr, de Sousa SO: Blue nevus: report of a case. Gen Dent; 2009 Jan-Feb;57(1):e1-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Blue nevus: report of a case.
  • Blue nevus is a benign, acquired melanocytic lesion that typically manifests as an asymptomatic, slate-blue or blue-black, smooth-surfaced macule or papule.
  • Intraoral melanocytic nevi are uncommon compared to those found in the skin, with the exception of the blue nevus.
  • The blue nevus is proportionally more prevalent in oral mucosa and represents the second most common form of nevus, accounting for 16.5% to 36% of all oral nevi.
  • The palate is the predominant location for blue nevi, accounting for 87% of all oral cases, although other lesions are found in this region as well.
  • This paper presents a case of common blue nevus of the hard palate in a 76-year-old woman, describes the clinical and histological aspects of the nevus, and discusses the difference between benign and malignant melanocytic lesion in the palate.
  • [MeSH-major] Mouth Mucosa / pathology. Mouth Neoplasms / pathology. Nevus, Blue / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Melanoma / pathology. Melanoma / surgery. Palate, Hard. Treatment Outcome

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21466995.001).
  • [ISSN] 0363-6771
  • [Journal-full-title] General dentistry
  • [ISO-abbreviation] Gen Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Cagnano E, Hershkovitz O, Zilka A, Bar-Ilan A, Golder A, Sion-Vardy N, Bogdanov-Berezovsky A, Mandelboim O, Benharroch D, Porgador A: Expression of ligands to NKp46 in benign and malignant melanocytes. J Invest Dermatol; 2008 Apr;128(4):972-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of ligands to NKp46 in benign and malignant melanocytes.
  • Human melanoma cell lines were shown to express ligands for the natural cytotoxicity receptor, NKp46, expressed by natural killer (NK) cells.
  • We aimed to examine the expression of ligands for NKp46 by various primary human melanocytic cells and melanocytic lesions.
  • Sections from primary nevi and melanomas were tested for expression of NKp46 ligands employing chimeric NKp46-Fc for staining.
  • The melanocytes present in the reticular dermis were negative for NKp46 ligands in common nevi; in malignant melanocytic lesions, the deeper melanocytes were focally positive.
  • In dermoepidermal junction of all melanocytic lesions, the melanocytes showed enhanced expression of NKp46 ligands.
  • Therefore, the results show (i) a correlation between the malignant potential of the lesion and the expression of NKp46 ligands in the reticular dermis, and (ii) enhanced expression of NKp46 ligands in the active proliferation zone (dermoepidermal junction) of nevi and melanomas.
  • The physiological role of NKp46 ligands in the progression of malignancy within melanocytic lesions should be explored further.
  • [MeSH-major] Melanoma / immunology. Melanoma / pathology. Nevus / immunology. Nevus / pathology. Receptors, Immunologic / immunology. Skin Neoplasms / immunology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17972960.001).
  • [ISSN] 1523-1747
  • [Journal-full-title] The Journal of investigative dermatology
  • [ISO-abbreviation] J. Invest. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ligands; 0 / NCR1 protein, human; 0 / Natural Cytotoxicity Triggering Receptor 1; 0 / Receptors, Immunologic
  •  go-up   go-down


68. Phan A, Touzet S, Dalle S, Ronger-Savlé S, Balme B, Thomas L: Acral lentiginous melanoma: histopathological prognostic features of 121 cases. Br J Dermatol; 2007 Aug;157(2):311-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acral lentiginous melanoma: histopathological prognostic features of 121 cases.
  • BACKGROUND: Acral lentiginous melanoma (ALM) is the fourth histopathological subtype of malignant melanoma, accounting for < 10% of all melanomas in white-skinned populations.
  • Several pathological parameters of interest in melanoma were evaluated for disease-free and specific survival with the Kaplan-Meier method and the Cox proportional hazards regression model.
  • Remnants of pre-existing naevus were found in four (3%) melanomas.
  • CONCLUSIONS: This is a detailed pathological study of a large cohort with ALM, an uncommon subtype of melanoma.
  • [MeSH-major] Melanoma / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Epidemiologic Methods. Female. Humans. Lymphatic Metastasis. Male. Mitotic Index. Neoplasm Invasiveness. Prognosis. Sentinel Lymph Node Biopsy

  • Genetic Alliance. consumer health - Acral Lentiginous Melanoma.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17596173.001).
  • [ISSN] 0007-0963
  • [Journal-full-title] The British journal of dermatology
  • [ISO-abbreviation] Br. J. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


69. Shields JA, Eagle RC Jr, Shields CL, Abrams G: Diffuse choroidal melanocytoma simulating melanoma in a child with ocular melanocytosis. Retin Cases Brief Rep; 2010;4(2):164-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffuse choroidal melanocytoma simulating melanoma in a child with ocular melanocytosis.
  • PURPOSE: To report a clinicopathologic correlation of an extensive, diffuse uveal melanocytoma (magnocellular nevus) simulating diffuse choroidal melanoma in a child.
  • Diffuse choroidal melanoma was suspected, and the eye was enucleated.
  • Histopathologically, the entire uveal tract was diffusely thickened because of a proliferation of benign cells typical of melanocytoma without evidence of melanoma.
  • CONCLUSION: Diffuse uveal melanocytoma is a rare variant of ocular melanocytosis that can cause reduced vision, overlying orange pigment, and retinal detachment, resembling a diffuse choroidal melanoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25390393.001).
  • [ISSN] 1935-1089
  • [Journal-full-title] Retinal cases & brief reports
  • [ISO-abbreviation] Retin Cases Brief Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


70. Panitsas KE, Boyd CA, Meredith D: Evidence that the rabbit proton-peptide co-transporter PepT1 is a multimer when expressed in Xenopus laevis oocytes. Pflugers Arch; 2006 Apr;452(1):53-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The amount of PepT1-FLAG cRNA injected into the oocytes was kept constant, while the amount of W294F-PepT1 cRNA was increased over the mole fraction range of 0 to 1.
  • As the mole fraction of injected W294F-PepT1 increased, the uptake of D: -Phe-L: -Gln decreased.

  • COS Scholar Universe. author profiles.
  • Xenbase. Xenbase .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell Tissue Res. 2002 Jan;307(1):139-42 [11810321.001]
  • [Cites] J Biol Chem. 2003 Nov 14;278(46):45045-8 [14519759.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Jun 20;306(1):177-85 [12788085.001]
  • [Cites] Biochim Biophys Acta. 1998 Aug 14;1373(1):277-81 [9733984.001]
  • [Cites] Angew Chem Int Ed Engl. 2000 Feb;39(3):505-508 [10671239.001]
  • [Cites] Biochemistry. 1998 Oct 27;37(43):15214-21 [9790685.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11235-40 [9736719.001]
  • [Cites] J Biol Chem. 2004 Apr 16;279(16):15795-8 [14715671.001]
  • [Cites] J Biol Chem. 2003 Dec 19;278(51):51833-40 [14532279.001]
  • [Cites] Annu Rev Physiol. 2004;66:361-84 [14977407.001]
  • [Cites] Eur J Pharmacol. 2003 Oct 31;479(1-3):229-36 [14612153.001]
  • [Cites] J Biol Chem. 2003 Jul 25;278(30):28274-83 [12746456.001]
  • [Cites] Pflugers Arch. 2004 Feb;447(5):610-8 [12905028.001]
  • [Cites] Nature. 1994 Apr 7;368(6471):563-6 [8139693.001]
  • [Cites] J Biol Chem. 2001 Nov 9;276(45):41870-8 [11551954.001]
  • [Cites] J Med Chem. 2003 Dec 18;46(26):5725-34 [14667225.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10055-60 [11526230.001]
  • [Cites] J Pharm Sci. 1998 Nov;87(11):1286-91 [9811478.001]
  • [Cites] Trends Cell Biol. 1999 Feb;9(2):57-60 [10087619.001]
  • [Cites] Curr Drug Metab. 2004 Feb;5(1):85-94 [14965252.001]
  • [Cites] J Am Soc Nephrol. 2003 Dec;14(12):3039-46 [14638903.001]
  • [Cites] Biochem Biophys Res Commun. 1997 Aug 28;237(3):577-82 [9299407.001]
  • [Cites] Development. 2005 May;132(10 ):2365-75 [15843412.001]
  • [Cites] Pflugers Arch. 2003 Jan;445(4):513-21 [12548398.001]
  • [Cites] Cell Mol Life Sci. 2000 May;57(5):754-78 [10892342.001]
  • [Cites] J Physiol. 1998 Nov 1;512 ( Pt 3):629-34 [9882198.001]
  • (PMID = 16465547.001).
  • [ISSN] 0031-6768
  • [Journal-full-title] Pflugers Archiv : European journal of physiology
  • [ISO-abbreviation] Pflugers Arch.
  • [Language] eng
  • [Grant] United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / PepT1 protein; 0 / RNA, Complementary; 0 / Symporters
  •  go-up   go-down


71. Saksena R, Ma X, Wade TK, Kovác P, Wade WF: Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa. Carbohydr Res; 2005 Oct 17;340(14):2256-69
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Ogawa CHO-BSA was inoculated at either a constant mass but differing moles, or equal moles but differing masses.

  • COS Scholar Universe. author profiles.
  • Immune Epitope Database and Analysis Resource. gene/protein/disease-specific - Related Immune Epitope Information .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16098493.001).
  • [ISSN] 0008-6215
  • [Journal-full-title] Carbohydrate research
  • [ISO-abbreviation] Carbohydr. Res.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI 47373; United States / Intramural NIH HHS / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antibodies, Bacterial; 0 / Glycoconjugates; 0 / Immunoglobulin M; 0 / Lipopolysaccharides; 0 / O Antigens; 0 / Peptide Fragments
  •  go-up   go-down


72. Fan FR, Mazzitelli CL, Brodbelt JS, Bard AJ: Electrochemical, spectroscopic, and mass spectrometric studies of the interaction of silver species with polyamidoamine dendrimers. Anal Chem; 2005 Jul 15;77(14):4413-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When the mole ratio of DDM to Ag+ is > or = 1, Ag+ binds with PAMAMG2OH to form a dominant 1:1 complex with a value of 1.1 x 10(7) M(-1).
  • When the mole ratio is < 1, q > or = 2.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16013854.001).
  • [ISSN] 0003-2700
  • [Journal-full-title] Analytical chemistry
  • [ISO-abbreviation] Anal. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


73. Cabanillas M, Aneiros A, Monteagudo B, Santos-García D, Suárez-Amor O, Ramírez-Santos A: Epidermal nevus syndrome associated with polyostotic fibrous dysplasia, CNS lipoma, and aplasia cutis. Dermatol Online J; 2009;15(10):7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidermal nevus syndrome associated with polyostotic fibrous dysplasia, CNS lipoma, and aplasia cutis.
  • Epidermal nevus syndrome is a rare congenital sporadic neurocutaneous disorder characterized by an epidermal nevus and various developmental abnormalities of the skin, eyes, nervous, cardiovascular and urogenital systems.
  • We describe a patient with an extensive epidermal nevus associated with various organ abnormalities, particularly polyostotic fibrous dysplasia, central nervous system lipoma, and aplasia cutis.
  • Our patient demonstrates the polymorphic spectrum of involvement in epidermal nevus syndrome.
  • [MeSH-major] Ectodermal Dysplasia / complications. Fibrous Dysplasia, Polyostotic / complications. Lipoma / complications. Neoplasms, Multiple Primary. Nevus / complications. Skin Neoplasms / complications. Spinal Cord Neoplasms / complications


74. Rothberg BE, Moeder CB, Kluger H, Halaban R, Elder DE, Murphy GF, Lazar A, Prieto V, Duncan LM, Rimm DL: Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Mod Pathol; 2008 Sep;21(9):1121-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions.
  • HMB45 is a mouse monoclonal antibody raised against Pmel17/gp100, a melanoma-specific marker, which is routinely used in the diagnosis of primary cutaneous malignant melanoma.
  • We re-evaluated the patterns of HMB45 staining across the 480-core 'SPORE melanoma progression array' containing lesions representing the spectrum of melanocytic lesions ranging from thin nevus to visceral metastasis using the fluorescence-based staining technique and automated quantitative analysis (AQUA) of the obtained digital images.
  • The methods validated the expected cytoplasmic HMB45 staining pattern in 70/108 malignant lesions and in the epithelial components of nevus specimens.
  • However, the fluorescence-based approach revealed a nuclear gp100 localization present in the dermal component of all nevi that was not seen before.
  • The thin (0.450+/-0.253) and thick (0.513+/-0.227) nevi had strongly positive mean ln(nuclear/non-nuclear AQUA score ratios), which are significantly higher than those from the group of malignant lesions (P<0.0001).
  • This finding was reproduced on a smaller but independent progression array composed of nevi and melanomas from the Yale Pathology archives (P<0.01).
  • The odds ratio associated with a sample being a nevus was 2.24 (95% CI: 1.87-2.69, P<0.0001) for each 0.1 unit increase of the ln(nuclear/non-nuclear AQUA score ratio) to yield an ROC curve with 0.93 units of area and a simultaneously maximized sensitivity of 0.92 and specificity of 0.80 for distinguishing benign nevi from malignant melanomas.
  • On the basis of this preliminary study, we propose that the ratio of nuclear to non-nuclear HMB45 staining may be useful for diagnostic challenges in melanocytic lesions.

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Biotechnol. 2006 Aug;24(8):914-6 [16900128.001]
  • [Cites] J Biol Chem. 2006 Jul 28;281(30):21198-208 [16682408.001]
  • [Cites] Am J Surg Pathol. 2007 Aug;31(8):1175-80 [17667539.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):657-62 [11257096.001]
  • [Cites] J Cell Biol. 2001 Feb 19;152(4):809-24 [11266471.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10698-703 [11526213.001]
  • [Cites] Mol Biol Cell. 2001 Nov;12(11):3451-64 [11694580.001]
  • [Cites] Pathology. 2002 Feb;34(1):6-12 [11902448.001]
  • [Cites] Arch Dermatol. 2002 May;138(5):625-8 [12020223.001]
  • [Cites] Nat Med. 2002 Nov;8(11):1323-7 [12389040.001]
  • [Cites] Int J Surg Pathol. 2003 Jan;11(1):11-5 [12598911.001]
  • [Cites] Am J Pathol. 1986 May;123(2):195-203 [3518473.001]
  • [Cites] Am J Surg Pathol. 1989 Aug;13(8):680-4 [2473661.001]
  • [Cites] Am J Surg Pathol. 1990 Aug;14(8):748-51 [2378395.001]
  • [Cites] J Cutan Pathol. 1991 Aug;18(4):261-3 [1939785.001]
  • [Cites] J Invest Dermatol. 1993 Mar;100(3):313S-317S [8440911.001]
  • [Cites] Semin Diagn Pathol. 1993 Feb;10(1):76-91 [8506418.001]
  • [Cites] Am J Dermatopathol. 1995 Dec;17(6):542-6 [8599465.001]
  • [Cites] J Cutan Pathol. 1995 Dec;22(6):502-17 [8835170.001]
  • [Cites] Cancer Res. 1997 Aug 1;57(15):3223-9 [9242453.001]
  • [Cites] J Cutan Pathol. 1997 Oct;24(9):580-1 [9404857.001]
  • [Cites] Am J Surg Pathol. 1998 Aug;22(8):976-82 [9706977.001]
  • [Cites] J Surg Oncol. 1999 Mar;70(3):150-60 [10102344.001]
  • [Cites] Cancer Res. 2005 May 1;65(9):3937-41 [15867394.001]
  • [Cites] J Cutan Pathol. 2006 Mar;33(3):207-15 [16466507.001]
  • [Cites] Pigment Cell Res. 2006 Jun;19(3):250-2; author reply 253-7 [16704461.001]
  • [Cites] J Cutan Pathol. 2007 Jul;34(7):576-80 [17576338.001]
  • (PMID = 18552823.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA121974-02; United States / NCI NIH HHS / CA / R01 CA114277; United States / NCI NIH HHS / CA / P50 CA121974-02; United States / NCI NIH HHS / CA / R01 CA114277-02; United States / NCI NIH HHS / CA / CA114277-02; United States / NCI NIH HHS / CA / R0-1 CA01142777; United States / NCI NIH HHS / CA / P50 CA121974; United States / NCI NIH HHS / CA / 1P50 CA121974
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Melanoma-Specific Antigens; 0 / Membrane Glycoproteins; 0 / Neoplasm Proteins; 0 / PMEL protein, human; 0 / Si protein, mouse; 0 / gp100 Melanoma Antigen
  • [Other-IDs] NLM/ NIHMS67484; NLM/ PMC2570478
  •  go-up   go-down


75. Prabhu MM, Baxi J, Malhothra A, Setty M, Sharma P: A perplexing case of gastrointestinal haemorrhage. Singapore Med J; 2006 Feb;47(2):159-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 25-year-old Nepali woman presented with severe anaemia and massive gastrointestinal haemorrhage after normal pregnancy following evacuation of a hydatiform mole.
  • [MeSH-major] Choriocarcinoma / pathology. Gastrointestinal Hemorrhage / etiology. Hydatidiform Mole, Invasive / pathology. Jejunal Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16435061.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Singapore
  • [Number-of-references] 12
  •  go-up   go-down


76. Agarwal A, Gupta S, Sharma RK: Role of oxidative stress in female reproduction. Reprod Biol Endocrinol; 2005;3:28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is growing literature on the effects of OS in female reproduction with involvement in the pathophysiology of preeclampsia, hydatidiform mole, free radical-induced birth defects and other situations such as abortions.
  • The review comprehensively explores the literature for evidence of the role of oxidative stress in conditions such as abortions, preeclampsia, hydatidiform mole, fetal embryopathies, preterm labour and preeclampsia and gestational diabetes.

  • MedlinePlus Health Information. consumer health - Female Infertility.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Obstet Invest. 2004;57(2):72-9 [14671414.001]
  • [Cites] J Gynecol Obstet Biol Reprod (Paris). 2003 Dec;32(8 Pt 2):S48-50 [14968070.001]
  • [Cites] RN. 2004 Jan;67(1):38-42; quiz 43 [14979192.001]
  • [Cites] Am J Pathol. 2004 Mar;164(3):1049-61 [14982858.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Mar;89(3):1452-8 [15001647.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2004 Mar 15;113(1):17-20 [15036704.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2004 Mar 15;113(1):21-5 [15036705.001]
  • [Cites] Obstet Gynecol. 2004 Apr;103(4):657-62 [15051555.001]
  • [Cites] Fertil Steril. 2004 Apr;81(4):973-6 [15066450.001]
  • [Cites] J Matern Fetal Neonatal Med. 2004 Jan;15(1):6-14 [15101606.001]
  • [Cites] Free Radic Res. 2004 Feb;38(2):185-91 [15104212.001]
  • [Cites] J Reprod Dev. 2004 Apr;50(2):215-25 [15118249.001]
  • [Cites] Obstet Gynecol. 2004 May;103(5 Pt 1):913-22 [15121565.001]
  • [Cites] Gynecol Obstet Invest. 2004;57(4):214-7 [14970668.001]
  • [Cites] J Reprod Med. 2004 Apr;49(4):289-93 [15134155.001]
  • [Cites] Int J Gynaecol Obstet. 2004 Jun;85 Suppl 1:S28-41 [15147852.001]
  • [Cites] Exp Biol Med (Maywood). 2004 Jun;229(6):546-52 [15169974.001]
  • [Cites] Reprod Biomed Online. 2004 Jun;8(6):616-27 [15169573.001]
  • [Cites] Eur J Gynaecol Oncol. 2004;25(3):333-5 [15171312.001]
  • [Cites] Reprod Biol Endocrinol. 2004 Jun 10;2:29 [15191613.001]
  • [Cites] Cancer Res. 2004 Jul 1;64(13):4577-84 [15231669.001]
  • [Cites] Fertil Steril. 2004 Jul;82(1):126-31 [15237000.001]
  • [Cites] N Engl J Med. 2004 Jul 8;351(2):159-69 [15247356.001]
  • [Cites] Virchows Arch. 2004 Jul;445(1):74-8 [15133663.001]
  • [Cites] Free Radic Biol Med. 2004 Sep 1;37(5):724-32 [15288129.001]
  • [Cites] Acta Obstet Gynecol Scand. 2004 Sep;83(9):857-60 [15315598.001]
  • [Cites] Theriogenology. 2004 Oct 1;62(7):1186-97 [15325546.001]
  • [Cites] Mutat Res. 2004 Sep;567(1):1-61 [15341901.001]
  • [Cites] Gynecol Endocrinol. 2004 May;18(5):278-90 [15346664.001]
  • [Cites] J Obstet Gynaecol (Tokyo 1995). 1995 Aug;21(4):401-9 [8775911.001]
  • [Cites] J Soc Gynecol Investig. 1996 Jan-Feb;3(1):33-8 [8796805.001]
  • [Cites] J Soc Gynecol Investig. 1996 Jul-Aug;3(4):179-84 [8796828.001]
  • [Cites] Hum Reprod. 1996 Sep;11(9):1947-51 [8921069.001]
  • [Cites] Fertil Steril. 1996 Dec;66(6):1036-8 [8941078.001]
  • [Cites] Hum Reprod. 1996 Nov;11(11):2484-7 [8981140.001]
  • [Cites] Hum Reprod. 1996 Nov;11(11):2493-5 [8981142.001]
  • [Cites] Hum Reprod. 1997 Jan;12(1):191-6 [9043927.001]
  • [Cites] Hum Reprod. 1997 Feb;12(2):301-5 [9070716.001]
  • [Cites] J Clin Invest. 1997 May 15;99(10):2502-8 [9153294.001]
  • [Cites] Hum Reprod. 1997 May;12(5):1047-55 [9194664.001]
  • [Cites] Br J Obstet Gynaecol. 1997 Jun;104(6):689-96 [9197872.001]
  • [Cites] Mol Hum Reprod. 1996 Aug;2(8):607-12 [9239673.001]
  • [Cites] Mol Hum Reprod. 1996 Oct;2(10):717-24 [9239688.001]
  • [Cites] Fertil Steril. 1997 Nov;68(5):826-30 [9389810.001]
  • [Cites] Hum Reprod. 1997 Dec;12(12):2810-5 [9455858.001]
  • [Cites] Fertil Steril. 1998 Feb;69(2):303-8 [9496346.001]
  • [Cites] Hum Reprod. 1998 Apr;13(4):998-1002 [9619561.001]
  • [Cites] Hum Reprod. 1998 Apr;13(4):1070-3 [9619572.001]
  • [Cites] Hum Reprod Update. 1998 Jan-Feb;4(1):3-24 [9622410.001]
  • [Cites] Fertil Steril. 1998 Jun;69(6):1092-4 [9627298.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Jun;83(6):2110-3 [9626147.001]
  • [Cites] Endocrine. 1998 Apr;8(2):185-91 [9704576.001]
  • [Cites] Rev Med Chil. 1998 May;126(5):481-7 [9731428.001]
  • [Cites] Mol Hum Reprod. 1999 Feb;5(2):175-81 [10065874.001]
  • [Cites] Exp Clin Endocrinol Diabetes. 1999;107(1):1-11 [10077349.001]
  • [Cites] Hum Reprod. 1999 Feb;14(2):465-9 [10099995.001]
  • [Cites] Diabetes. 1999 Apr;48(4):813-20 [10102698.001]
  • [Cites] Nat Med. 1999 May;5(5):582-5 [10229238.001]
  • [Cites] Hum Reprod. 2002 Oct;17(10):2615-20 [12351537.001]
  • [Cites] Hum Reprod. 2002 Oct;17(10):2686-93 [12351549.001]
  • [Cites] J Steroid Biochem Mol Biol. 2002 Aug;81(4-5):327-32 [12361722.001]
  • [Cites] Fertil Steril. 2002 Oct;78(4):860-4 [12372469.001]
  • [Cites] Fertil Steril. 2002 Nov;78(5):1073-6 [12413996.001]
  • [Cites] Am J Pathol. 2003 Jan;162(1):115-25 [12507895.001]
  • [Cites] J Perinat Med. 2002;30(6):447-57 [12530100.001]
  • [Cites] Mol Hum Reprod. 2003 Mar;9(3):165-9 [12606593.001]
  • [Cites] Reprod Biomed Online. 2003 Jan-Feb;6(1):15-23 [12626139.001]
  • [Cites] Reprod Biomed Online. 2003 Jan-Feb;6(1):84-96 [12626148.001]
  • [Cites] Fertil Steril. 2003 Apr;79(4):829-43 [12749418.001]
  • [Cites] Hum Reprod. 2003 Jun;18(6):1259-64 [12773456.001]
  • [Cites] Fertil Steril. 2003 Jun;79(6):1288-93 [12798872.001]
  • [Cites] Am J Obstet Gynecol. 2003 Jul;189(1):181-8 [12861160.001]
  • [Cites] Am J Obstet Gynecol. 2003 Jul;189(1):280-94 [12861175.001]
  • [Cites] Mol Reprod Dev. 2003 Sep;66(1):24-31 [12874795.001]
  • [Cites] Cent Eur J Public Health. 2003 Jun;11(2):63-7 [12884545.001]
  • [Cites] In Vitro Cell Dev Biol Anim. 2003 Jan-Feb;39(1-2):98-105 [12892533.001]
  • [Cites] Fertil Steril. 2003 Aug;80(2):459-61 [12909517.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2003 Sep 22;110 Suppl 1:S2-9 [12965085.001]
  • [Cites] Clin Evid. 2003 Jun;(9):2044-73 [12967463.001]
  • [Cites] J Obstet Gynaecol Can. 2003 Sep;25(9):742-50 [12970809.001]
  • [Cites] Hum Reprod. 2003 Oct;18(10):2039-47 [14507818.001]
  • [Cites] Am J Obstet Gynecol. 2003 Aug;189(2):519-25 [14520228.001]
  • [Cites] Fertil Steril. 2003 Dec;80(6):1454-60 [14667883.001]
  • [Cites] Fertil Steril. 2003 Dec;80(6):1524-5 [14667898.001]
  • [Cites] Swiss Med Wkly. 2003 Nov 1;133(41-42):563-6 [14691728.001]
  • [Cites] Am J Obstet Gynecol. 2003 Dec;189(6):1720-5 [14710104.001]
  • [Cites] Antioxid Redox Signal. 2004 Feb;6(1):147-53 [14713346.001]
  • [Cites] Virchows Arch. 2004 Jan;444(1):49-55 [14574573.001]
  • [Cites] Hum Reprod. 2000 Jun;15(6):1295-9 [10831558.001]
  • [Cites] Mol Hum Reprod. 2000 Aug;6(8):681-7 [10908276.001]
  • [Cites] Acta Obstet Gynecol Scand. 2000 Jul;79(7):564-9 [10929956.001]
  • [Cites] J Assist Reprod Genet. 2000 Apr;17(4):222-8 [10955247.001]
  • [Cites] Fertil Steril. 2000 Sep;74(3):429-38 [10973633.001]
  • [Cites] Am J Obstet Gynecol. 2000 Oct;183(4):979-85 [11035350.001]
  • [Cites] Hum Reprod. 2000 Jul;15 Suppl 2:199-206 [11041525.001]
  • [Cites] Fertil Steril. 2000 Nov;74(5):1014-9 [11056251.001]
  • [Cites] Int J Fertil Womens Med. 2000 Sep-Oct;45(5):314-20 [11092702.001]
  • [Cites] Toxicology. 2000 Nov 16;153(1-3):83-104 [11090949.001]
  • [Cites] Hum Reprod. 2000 Dec;15(12):2512-9 [11098019.001]
  • [Cites] Am J Pathol. 2000 Dec;157(6):2111-22 [11106583.001]
  • [Cites] Fertil Steril. 2000 Dec;74(6):1257-8 [11119764.001]
  • [Cites] Hum Reprod Update. 2000 Nov-Dec;6(6):532-49 [11129687.001]
  • [Cites] Am J Reprod Immunol. 2000 Dec;44(6):359-64 [11200815.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2001 Feb;94(2):261-3 [11165736.001]
  • [Cites] Placenta. 2001 Jan;22(1):1-13 [11162347.001]
  • [Cites] J Soc Gynecol Investig. 2001 Jan-Feb;8(1 Suppl Proceedings):S40-2 [11223371.001]
  • [Cites] Hum Reprod Update. 2001 Mar-Apr;7(2):175-89 [11284661.001]
  • [Cites] Biochem Biophys Res Commun. 2001 Apr 20;282(5):1075-9 [11302723.001]
  • [Cites] Placenta. 2001 Apr;22 Suppl A:S45-50 [11312628.001]
  • [Cites] Semin Reprod Med. 2000;18(4):331-9 [11355791.001]
  • [Cites] Hum Reprod. 2001 Jul;16(7):1334-9 [11425809.001]
  • [Cites] Med Sci Monit. 2001 Jul-Aug;7(4):801-19 [11433215.001]
  • [Cites] Hum Reprod. 2001 Sep;16(9):1797-801 [11527878.001]
  • [Cites] J Reprod Med. 2001 Oct;46(10):887-91 [11725732.001]
  • [Cites] Fertil Steril. 2002 Jan;77(1):46-51 [11779590.001]
  • [Cites] Hum Reprod. 2002 Feb;17(2):426-31 [11821289.001]
  • [Cites] Hum Reprod. 2002 Mar;17(3):659-65 [11870119.001]
  • [Cites] Reprod Biomed Online. 2004 Sep;9(3):338-47 [15353087.001]
  • [Cites] Fertil Steril. 2004 Sep;82 Suppl 1:S24-5 [15363689.001]
  • [Cites] Fertil Steril. 2004 Sep;82 Suppl 1:S206 [15363731.001]
  • [Cites] Reprod Fertil Dev. 2004;16(5):581-8 [15367373.001]
  • [Cites] Endothelium. 2004 Mar-Apr;11(2):133-9 [15370072.001]
  • [Cites] Fertil Steril. 2004 Sep;82(3):586-92 [15374700.001]
  • [Cites] Fertil Steril. 2004 Sep;82(3):593-600 [15374701.001]
  • [Cites] Mol Hum Reprod. 2004 Oct;10(10):713-7 [15299090.001]
  • [Cites] J Bioenerg Biomembr. 2004 Aug;36(4):335-40 [15377868.001]
  • [Cites] Nutr Rev. 2004 Jul;62(7 Pt 1):269-75 [15384917.001]
  • [Cites] Am J Obstet Gynecol. 2004 Sep;191(3):733-40 [15467532.001]
  • [Cites] Int J Gynaecol Obstet. 2004 Oct;87(1):66-71 [15464786.001]
  • [Cites] J Nutr. 2004 Oct;134(10):2556-60 [15465747.001]
  • [Cites] Fertil Steril. 2004 Oct;82 Suppl 3:1019-22 [15474067.001]
  • [Cites] Fertil Steril. 2004 Oct;82 Suppl 3:1171-6 [15474091.001]
  • [Cites] Histochem Cell Biol. 2004 Oct;122(4):369-82 [15248072.001]
  • [Cites] J Nutr. 2004 Nov;134(11):3199S-3200S [15514306.001]
  • [Cites] Placenta. 1980 Jan-Mar;1(1):3-19 [7443635.001]
  • [Cites] Biochem J. 1984 Feb 15;218(1):273-5 [6712613.001]
  • [Cites] Am J Reprod Immunol Microbiol. 1987 Mar;13(3):78-82 [3605484.001]
  • [Cites] Int J Epidemiol. 1989 Sep;18(3):538-45 [2807655.001]
  • [Cites] Int J Fertil. 1991 Jan-Feb;36(1):39-42 [1672675.001]
  • [Cites] Hum Reprod. 1991 Nov;6(10):1349-53 [1770125.001]
  • [Cites] J Lab Clin Med. 1992 Jun;119(6):598-620 [1593209.001]
  • [Cites] Endocrinology. 1994 Nov;135(5):1799-806 [7525252.001]
  • [Cites] Fertil Steril. 1995 Jan;63(1):198-9 [7805914.001]
  • [Cites] Hum Reprod. 1995 Jan;10(1):19-23 [7538147.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Sep;80(9):2815-21 [7673429.001]
  • [Cites] Clin Chim Acta. 1995 May 15;236(2):173-80 [7554284.001]
  • [Cites] Hum Reprod. 1995 Jul;10(7):1786-90 [8582980.001]
  • [Cites] J Endocrinol. 1995 Oct;147(1):177-82 [7490532.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jan;81(1):353-9 [8550777.001]
  • [Cites] Am J Obstet Gynecol. 1996 Mar;174(3):914-8 [8633668.001]
  • [Cites] Hum Reprod. 1996 May;11(5):1073-8 [8671393.001]
  • [Cites] Hum Reprod. 1996 Jul;11(7):1542-51 [8671502.001]
  • [Cites] Placenta. 1999 May;20(4):265-72 [10329346.001]
  • [Cites] Mol Hum Reprod. 1999 May;5(5):409-13 [10338363.001]
  • [Cites] Fertil Steril. 1999 Jun;71(6):1115-8 [10360920.001]
  • [Cites] Hum Reprod. 1999 Jul;14(7):1690-7 [10402369.001]
  • [Cites] Acta Obstet Gynecol Scand. 1999 Aug;78(7):626-31 [10422910.001]
  • [Cites] Mol Hum Reprod. 1999 Aug;5(8):720-5 [10421798.001]
  • [Cites] Fertil Steril. 1999 Jul;72(1):154-7 [10428165.001]
  • [Cites] Andrologia. 1999 Jul;31(4):195-8 [10470408.001]
  • [Cites] J Natl Cancer Inst. 1999 Sep 1;91(17):1459-67 [10469746.001]
  • [Cites] Lancet. 1999 Sep 4;354(9181):810-6 [10485722.001]
  • [Cites] Mol Hum Reprod. 1999 Oct;5(10):914-9 [10508218.001]
  • [Cites] Fertil Steril. 1999 Oct;72(4):720-6 [10521117.001]
  • [Cites] Ginekol Pol. 2004 Aug;75(8):649-57 [15517790.001]
  • [Cites] Zygote. 2004 Aug;12(3):231-40 [15521713.001]
  • [Cites] Mol Cell Biochem. 2004 Sep;264(1-2):85-97 [15544038.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):47-51 [15596272.001]
  • [Cites] Hum Reprod. 2005 Jan;20(1):302-6 [15471931.001]
  • [Cites] J Matern Fetal Neonatal Med. 2004 Dec;16(6):367-72 [15621558.001]
  • [Cites] Free Radic Res. 2004 Sep;38(9):913-8 [15621708.001]
  • [Cites] BMJ. 2003 Oct 11;327(7419):852-5 [14551103.001]
  • [Cites] Minerva Ginecol. 2003 Aug;55(4):333-45 [14581858.001]
  • [Cites] Hum Reprod. 2003 Nov;18(11):2270-4 [14585872.001]
  • [Cites] Ann Acad Med Singapore. 2003 Sep;32(5):611-3; quiz 614 [14626788.001]
  • [Cites] Hum Reprod. 2003 Dec;18(12):2668-71 [14645189.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Feb;90(2):944-52 [15585559.001]
  • [Cites] Gynecol Obstet Invest. 1999;48 Suppl 1:29-35 [10559662.001]
  • [Cites] Fertil Steril. 1999 Dec;72(6):1027-34 [10593376.001]
  • [Cites] Mol Hum Reprod. 2000 Jan;6(1):19-25 [10611256.001]
  • [Cites] Mol Hum Reprod. 2000 Feb;6(2):185-90 [10655461.001]
  • [Cites] FASEB J. 2000 Jan;14(1):111-27 [10627286.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2000 Mar;89(1):47-54 [10733023.001]
  • [Cites] Theriogenology. 2000 Feb;53(3):761-71 [10735042.001]
  • [Cites] Hum Reprod. 2000 Apr;15(4):806-9 [10739824.001]
  • [Cites] Clin Chim Acta. 2000 May;295(1-2):169-77 [10767402.001]
  • [Cites] Mol Hum Reprod. 2000 May;6(5):397-403 [10775642.001]
  • [Cites] Ginekol Pol. 2001 Dec;72(12):1073-8 [11883212.001]
  • [Cites] Biol Reprod. 2002 Apr;66(4):1151-60 [11906936.001]
  • [Cites] Reproduction. 2002 Apr;123(4):479-86 [11914110.001]
  • [Cites] Hum Reprod. 2002 Apr;17(4):921-5 [11925382.001]
  • [Cites] Am J Obstet Gynecol. 2002 Apr;186(4):745-50 [11967501.001]
  • [Cites] Fertil Steril. 2002 May;77(5):861-70 [12009336.001]
  • [Cites] J Assist Reprod Genet. 2002 Apr;19(4):164-8 [12036083.001]
  • [Cites] Fertil Steril. 2002 Jun;77(6):1184-90 [12057726.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Aug;87(8):3845-50 [12161520.001]
  • [Cites] BJOG. 2002 Aug;109(8):938-41 [12197375.001]
  • [Cites] Nihon Sanka Fujinka Gakkai Zasshi. 1993 Aug;45(8):842-8 [8371013.001]
  • [Cites] Can J Physiol Pharmacol. 1993 Sep;71(9):725-31 [8313238.001]
  • [Cites] Lancet. 1994 May 28;343(8909):1325-6 [7910325.001]
  • [Cites] Am J Obstet Gynecol. 1994 Jul;171(1):150-7 [8030691.001]
  • [Cites] Biol Reprod. 1994 Aug;51(2):310-8 [7524699.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):29-38 [15539615.001]
  • [Cites] Biofactors. 2004;21(1-4):223-32 [15630201.001]
  • [Cites] Antioxid Redox Signal. 2005 Jan-Feb;7(1-2):129-43 [15650402.001]
  • [Cites] Curr Hypertens Rep. 2005 Feb;7(1):61-7 [15683588.001]
  • [Cites] Am J Obstet Gynecol. 2005 Feb;192(2):520-1 [15695996.001]
  • (PMID = 16018814.001).
  • [ISSN] 1477-7827
  • [Journal-full-title] Reproductive biology and endocrinology : RB&E
  • [ISO-abbreviation] Reprod. Biol. Endocrinol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Reactive Oxygen Species; EC 1.14.13.39 / Nitric Oxide Synthase
  • [Number-of-references] 212
  • [Other-IDs] NLM/ PMC1215514
  •  go-up   go-down


77. Jakobiec FA, Bhat P, Colby KA: Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol; 2010 Feb;128(2):174-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical studies of conjunctival nevi and melanomas.
  • OBJECTIVE: To evaluate the role of immunohistochemical methods in the diagnosis of benign and malignant conjunctival melanocytic proliferations.
  • METHODS: Paraffin-embedded tissue sections from 20 conjunctival nevi and 15 invasive melanomas were immunoreacted with antibodies against cellular antigens S-100 protein, MART-1, HMB-45, CD-45, and Ki-67 nuclear proliferation protein.
  • RESULTS: All nevi immunostained moderately to strongly for S-100 protein and MART-1.
  • Only 1 melanoma did not stain positively for S-100; MART-1 and HMB-45 were positive in all lesions at some level of intensity.
  • Ki-67 positivity was restricted to the junctional zone of nevi and was diffuse in melanomas.
  • The mean Ki-67 proliferation indices were 1.89% for the nevi and 17.3% for the melanomas.
  • CONCLUSIONS: S-100 and MART-1 were not useful in separating benign from malignant lesions.
  • Results for nevus cells beneath the junctional zone were overwhelmingly negative for HMB-45 and Ki-67.
  • Two nevi and all melanomatous nodules were positive for HMB-45 (P < .001).
  • A higher Ki-67 proliferation index convincingly separated melanomas from nevi (P < .001).
  • Immunostaining for HMB-45 and Ki-67 are valuable adjuncts to careful histopathologic evaluation in assessing benign and malignant conjunctival melanocytic tumors.
  • [MeSH-major] Biomarkers, Tumor / analysis. Conjunctival Neoplasms / diagnosis. Melanoma / diagnosis. Neoplasm Proteins / analysis. Nevus, Pigmented / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD45 / analysis. Antigens, Neoplasm / analysis. Child. Diagnosis, Differential. Female. Humans. Immunoenzyme Techniques. Ki-67 Antigen / analysis. MART-1 Antigen. Male. Melanoma-Specific Antigens. Middle Aged. Retrospective Studies. S100 Proteins / analysis. Young Adult

  • MedlinePlus Health Information. consumer health - Melanoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20142539.001).
  • [ISSN] 1538-3601
  • [Journal-full-title] Archives of ophthalmology (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch. Ophthalmol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins; 0 / S100 Proteins; EC 3.1.3.48 / Antigens, CD45; EC 3.1.3.48 / PTPRC protein, human
  •  go-up   go-down


78. Klecka GM, Naylor CG, Staples CA, Losey B: Occurrence of nonylphenol ethoxylates and their metabolites in municipal wastewater treatment plants and receiving waters. Water Environ Res; 2010 May;82(5):447-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, three municipal activated sludge WWTPs, receiving primarily residential wastewater, were monitored, with their receiving waters, to determine the occurrence of NPEs and their biodegradation metabolites, including nonylphenol (NP), low-mole and higher-mole nonylphenol ethoxylates (NPE1, NPE2-8, and NPE > or =9), and nonylphenol ether carboxylates (NPECs).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20480766.001).
  • [ISSN] 1061-4303
  • [Journal-full-title] Water environment research : a research publication of the Water Environment Federation
  • [ISO-abbreviation] Water Environ. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ethylene Glycols; 0 / Water Pollutants, Chemical; 27986-36-3 / terics
  •  go-up   go-down


79. Horn EM, Nakaji P, Coons SW, Dickman CA: Surgical treatment for intramedullary spinal cord melanocytomas. J Neurosurg Spine; 2008 Jul;9(1):48-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Spinal meningeal melanocytomas are rare lesions that are histologically benign and can behave aggressively, with local infiltration.
  • Three patients were identified in whom spinal melanocytoma had been diagnosed between 1989 and 2006.
  • [MeSH-major] Nevus, Pigmented / surgery. Spinal Cord Neoplasms / surgery
  • [MeSH-minor] Adult. Cervical Vertebrae. Disease Progression. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies. Thoracic Vertebrae. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18590410.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 46
  •  go-up   go-down


80. Gupta N, Day AS: Editorial comment: blue rubber bleb naevus syndrome. J Paediatr Child Health; 2010 Jan;46(1-2):67-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Editorial comment: blue rubber bleb naevus syndrome.
  • [MeSH-major] Gastrointestinal Hemorrhage / diagnosis. Intestine, Small / physiopathology. Nevus, Blue / pathology. Skin Neoplasms / physiopathology

  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Paediatr Child Health. 2010 Jan;46(1-2):63-5 [19943859.001]
  • [CommentOn] J Paediatr Child Health. 2010 Jan;46(1-2):68-9 [20412197.001]
  • (PMID = 20412196.001).
  • [ISSN] 1440-1754
  • [Journal-full-title] Journal of paediatrics and child health
  • [ISO-abbreviation] J Paediatr Child Health
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] Australia
  •  go-up   go-down


81. Sebire NJ: Hydatidiform mole and medical management of miscarriage. BMJ; 2006 Jun 17;332(7555):1454
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hydatidiform mole and medical management of miscarriage.
  • [MeSH-major] Abortion, Spontaneous / drug therapy. Hydatidiform Mole / complications. Uterine Neoplasms / complications


82. Hughes SM, Wilkerson AE, Winfield HL, Hiatt KM: Familial nevus sebaceus in dizygotic male twins. J Am Acad Dermatol; 2006 Feb;54(2 Suppl):S47-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Familial nevus sebaceus in dizygotic male twins.
  • [MeSH-major] Diseases in Twins / genetics. Hamartoma / genetics. Scalp / pathology. Sebaceous Glands / pathology. Skin Diseases / genetics

  • Genetic Alliance. consumer health - Nevus.
  • Genetic Alliance. consumer health - Dizygotic twins.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16427992.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter; Research Support, Non-U.S. Gov't; Twin Study
  • [Publication-country] United States
  •  go-up   go-down


83. Ng EK, Cheung FK, Chiu PW: Blue rubber bleb nevus syndrome: treatment of multiple gastrointestinal hemangiomas with argon plasma coagulator. Dig Endosc; 2009 Jan;21(1):40-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Blue rubber bleb nevus syndrome: treatment of multiple gastrointestinal hemangiomas with argon plasma coagulator.
  • Blue rubber bleb nevus syndrome is a rare clinical entity characterized by the formation of multiple blue or purplish rubbery cavernous hemangiomas on the skin and other epithelial surfaces.

  • Genetic Alliance. consumer health - Nevus.
  • Genetic Alliance. consumer health - Blue Rubber Bleb Nevus.
  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19691801.001).
  • [ISSN] 1443-1661
  • [Journal-full-title] Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
  • [ISO-abbreviation] Dig Endosc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


84. Chander R, Varghese B, Jabeen M, Garg T, Jain M: CHILD syndrome with thrombocytosis and congenital dislocation of hip: A case report from India. Dermatol Online J; 2010;16(8):6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Congenital Hemidysplasia with Ichthyosiform Nevus and Limb Defects (CHILD) is a very rare entity inherited as an X-linked trait.
  • [MeSH-major] Hip Dislocation, Congenital / diagnosis. Ichthyosiform Erythroderma, Congenital / diagnosis. Limb Deformities, Congenital / diagnosis. Nevus / diagnosis. Skin Neoplasms / diagnosis. Thrombocytosis / diagnosis

  • Genetic Alliance. consumer health - CHILD Syndrome.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20804683.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dermatologic Agents; 0 / Emollients
  •  go-up   go-down


85. Bataille V: Early detection of melanoma improves survival. Practitioner; 2009 Oct;253(1722):29-32, 3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early detection of melanoma improves survival.
  • Melanoma affects 15 to 20 per 100, 000 in the UK.
  • Cancers such as breast and prostate are around ten times more common than melanoma.
  • It is the most common cancer between the age of 20 and 35 years in Caucasians but the incidence of melanoma is still very low in that age group.
  • Melanoma has different clinical presentations with different outcomes and management.
  • They may grow from a pre-existing naevus but also from normal skin.
  • Melanoma can appear on the palms and soles or under the nail and on those sites may present as a vascular non-pigmented lesion which may cause diagnostic problems.
  • Subjects with fair skin and hair have a two-fold increased risk of melanoma.
  • The presence of > 100 naevi with atypical naevi can increase the risk of melanoma five-to ten-fold.
  • Any new mole in a subject over 40 should be regarded as suspicious.
  • [MeSH-major] Melanoma / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19938560.001).
  • [ISSN] 0032-6518
  • [Journal-full-title] The Practitioner
  • [ISO-abbreviation] Practitioner
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


86. Széll M, Balogh K, Dobozy A, Kemény L, Oláh J: First detection of the melanoma-predisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary? Melanoma Res; 2007 Aug;17(4):251-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] First detection of the melanoma-predisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary?
  • The P48T germ line mutation of p16 was detected in a Hungarian multiple primary melanoma patient (deceased at the age of 39) with no affected family members.
  • Genetic analysis of the patient and his family revealed that the patient was homozygous for the mutation, whereas his parents (father currently aged 69 and mother 63), who are free from any malignancies and atypical moles, are both heterozygous for the mutation.
  • Our data suggest that the P48T mutation of p16 is a strong melanoma-predisposing factor, but the fact that the heterozygous mutant parents have not yet exhibited melanoma or atypical moles indicates that the penetrance of this allele might depend on modifying factors.
  • Here, we first report the inheritance of the rare P48T mutation of CDKN2A in a Hungarian family with a homozygous multiple primary melanoma member and unaffected heterozygous family members.
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p16 / genetics. Founder Effect. Germ-Line Mutation. Melanoma / diagnosis. Melanoma / genetics. Proline / chemistry. Skin Neoplasms / diagnosis. Skin Neoplasms / genetics. Threonine / chemistry

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. (L)-PROLINE .
  • Hazardous Substances Data Bank. L-Threonine .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17625456.001).
  • [ISSN] 0960-8931
  • [Journal-full-title] Melanoma research
  • [ISO-abbreviation] Melanoma Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p16; 2ZD004190S / Threonine; 9DLQ4CIU6V / Proline
  •  go-up   go-down


87. Ahyayauch H, Larijani B, Alonso A, Goñi FM: Detergent solubilization of phosphatidylcholine bilayers in the fluid state: influence of the acyl chain structure. Biochim Biophys Acta; 2006 Feb;1758(2):190-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For each case, the solubilization parameters, Don (total detergent: lipid mole ratio producing the onset of solubilization) and D50 (total detergent: lipid mole ratio producing 50% solubilization), were determined under equilibrium conditions.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16579963.001).
  • [ISSN] 0006-3002
  • [Journal-full-title] Biochimica et biophysica acta
  • [ISO-abbreviation] Biochim. Biophys. Acta
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Detergents; 0 / Lipid Bilayers; 0 / Phosphatidylcholines; 9002-93-1 / Octoxynol
  •  go-up   go-down


88. Avgerinou GP, Asvesti AP, Katsambas AD, Nikolaou VA, Christofidou EC, Grzeschik KH, Happle R: CHILD syndrome: the NSDHL gene and its role in CHILD syndrome, a rare hereditary disorder. J Eur Acad Dermatol Venereol; 2010 Jun;24(6):733-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CHILD syndrome: the NSDHL gene and its role in CHILD syndrome, a rare hereditary disorder.
  • BACKGROUND: CHILD syndrome, a rare hereditary disorder of keratinization (MIM 308050, 300275), is the acronym proposed by Happle to name a rare entity, characterized by congenital hemidysplasia, icthyosiform nevus and limb defects, ranging from digital hypoplasia to icthyosiform nevus and ipsilateral limb defects, ranging from digital hypoplasia to complete amelia.
  • PATIENTS AND METHODS: A 9-month-old female infant presented with skin and limb defects involving the right side of her body.
  • [MeSH-major] 3-Hydroxysteroid Dehydrogenases / genetics. Erythema / genetics. Limb Deformities, Congenital / genetics. Nevus / genetics

  • Genetic Alliance. consumer health - CHILD Syndrome.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Moles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19906044.001).
  • [ISSN] 1468-3083
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Databank-accession-numbers] OMIM/ 300275/ 308050
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] EC 1.1.- / 3-Hydroxysteroid Dehydrogenases; EC 1.1.1.170 / Nsdhl protein, human
  •  go-up   go-down


89. Drescher M, Godschalk F, Veldhuis G, van Rooijen BD, Subramaniam V, Huber M: Spin-label EPR on alpha-synuclein reveals differences in the membrane binding affinity of the two antiparallel helices. Chembiochem; 2008 Oct 13;9(15):2411-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Protein binding to POPC/POPG vesicles for all but alphaS140 resulted in two mobility components with correlation times of 0.5 and 3 ns, for POPG mole fractions >0.4.
  • Monitoring these components as a function of the POPG mole fraction revealed that at low negative-charge densities helix 1 is more tightly bound than helix 2; this indicates a partially bound form of alphaS.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18821550.001).
  • [ISSN] 1439-7633
  • [Journal-full-title] Chembiochem : a European journal of chemical biology
  • [ISO-abbreviation] Chembiochem
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Membranes, Artificial; 0 / Spin Labels; 0 / alpha-Synuclein
  •  go-up   go-down


90. Sterry W: [Innovative control of extreme nevus dysplasia syndromes]. J Dtsch Dermatol Ges; 2009 Sep;7(9):733
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Innovative control of extreme nevus dysplasia syndromes].
  • [MeSH-major] Nevus, Pigmented / prevention & control. Precancerous Conditions / prevention & control. Skin Neoplasms / prevention & control

  • Genetic Alliance. consumer health - Nevus.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19712225.001).
  • [ISSN] 1610-0387
  • [Journal-full-title] Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  • [ISO-abbreviation] J Dtsch Dermatol Ges
  • [Language] ger
  • [Publication-type] Editorial
  • [Publication-country] Germany
  •  go-up   go-down


91. Dominguez-Cherit J, Toussaint-Caire S, Kamino H, Iorizzo M, Tosti A: Subungual spitz nevus in a Hispanic infant. Dermatol Surg; 2008 Nov;34(11):1571-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subungual spitz nevus in a Hispanic infant.
  • [MeSH-major] Nail Diseases. Nevus, Epithelioid and Spindle Cell. Skin Neoplasms

  • Genetic Alliance. consumer health - Nevus.
  • Genetic Alliance. consumer health - Spitz nevus.
  • MedlinePlus Health Information. consumer health - Nail Diseases.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18798747.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Lee WJ, Chang SE, Lee MW, Choi JH, Moon KC, Koh JK, Bak H: Bilateral mucinous eccrine nevus in an adult. J Dermatol; 2008 Aug;35(8):552-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral mucinous eccrine nevus in an adult.

  • Genetic Alliance. consumer health - Nevus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18789080.001).
  • [ISSN] 0385-2407
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Japan
  • [Chemical-registry-number] F446C597KA / Triamcinolone Acetonide
  •  go-up   go-down


93. Patel RC, Zynger DL, Laskin WB: Blue rubber bleb nevus syndrome: novel lymphangiomatosis-like growth pattern within the uterus and immunohistochemical analysis. Hum Pathol; 2009 Mar;40(3):413-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Blue rubber bleb nevus syndrome: novel lymphangiomatosis-like growth pattern within the uterus and immunohistochemical analysis.
  • Blue Rubber Bleb Nevus Syndrome is a rare, primarily sporadic condition characterized by vascular lesions principally involving the skin and gastrointestinal tract.
  • This case of Blue Rubber Bleb Nevus Syndrome demonstrated a labyrinth of variably sized vascular spaces lined by an attenuated layer of bland endothelial cells, dissecting uterine tissues and sequestering remaining myometrium.
  • This report expands the morphological spectrum of vascular lesions in Blue Rubber Bleb Nevus Syndrome to include a lymphangiomatosis-like growth pattern and the immunohistochemistry suggests dual vascular and lymphatic differentiation, supporting the current belief that these lesions are malformations.
  • [MeSH-major] Lymphangioma / pathology. Nevus, Blue / pathology. Uterine Neoplasms / pathology


94. Hoffner L, Parks WT, Swerdlow SH, Carson JC, Surti U: Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies. J Reprod Med; 2010 May-Jun;55(5-6):219-28
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The unusual cases included androgenetic/ biparental chimeric complete hydatidiform moles (CHM) and mosaic partial hydatidiform moles (PHM).
  • [MeSH-major] Autoantibodies / analysis. Chimera / genetics. Cyclin-Dependent Kinase Inhibitor p57 / genetics. Hydatidiform Mole / genetics. Uterine Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20626178.001).
  • [ISSN] 0024-7758
  • [Journal-full-title] The Journal of reproductive medicine
  • [ISO-abbreviation] J Reprod Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Autoantibodies; 0 / Cyclin-Dependent Kinase Inhibitor p57
  •  go-up   go-down


95. Tunc I, Guvenc HO, Sezen H, Suzer S, Correa-Duarte MA, Liz-Marzán LM: Optical response of Ag-Au bimetallic nanoparticles to electron storage in aqueous medium. J Nanosci Nanotechnol; 2008 Jun;8(6):3003-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The extent of this blue shift increases non-linearly with the mole fraction of silver in the nanoparticle, parallel to the trends reported previously for both the frequency and the extinction coefficient of the plasmon band shifts.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18681038.001).
  • [ISSN] 1533-4880
  • [Journal-full-title] Journal of nanoscience and nanotechnology
  • [ISO-abbreviation] J Nanosci Nanotechnol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Dinda E, Si S, Kotal A, Mandal TK: Novel ascorbic acid based ionic liquids for the in situ synthesis of quasi-spherical and anisotropic gold nanostructures in aqueous medium. Chemistry; 2008;14(18):5528-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It has been found that the nature of the ionic liquids and the mole ratio of ionic liquid to HAuCl4 has a significant effect on the morphology of the formed gold nanostructures.

  • MedlinePlus Health Information. consumer health - Vitamin C.
  • Hazardous Substances Data Bank. Sodium ascorbate .
  • Hazardous Substances Data Bank. L-Ascorbic Acid .
  • Hazardous Substances Data Bank. GOLD, ELEMENTAL .
  • Hazardous Substances Data Bank. Water .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18470852.001).
  • [ISSN] 0947-6539
  • [Journal-full-title] Chemistry (Weinheim an der Bergstrasse, Germany)
  • [ISO-abbreviation] Chemistry
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 059QF0KO0R / Water; 7440-57-5 / Gold; PQ6CK8PD0R / Ascorbic Acid
  •  go-up   go-down


97. Hayley M, Perera A, Robinson JJ: Biochemical analysis of a Ca2+-dependent membrane-membrane interaction mediated by the sea urchin yolk granule protein, toposome. Dev Growth Differ; 2006 Aug;48(6):401-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Monophasic binding of up to 600 M of calcium per mole of protein was detected with an intrinsic dissociation constant (calcium) of 240 microm.

  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16872453.001).
  • [ISSN] 0012-1592
  • [Journal-full-title] Development, growth & differentiation
  • [ISO-abbreviation] Dev. Growth Differ.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Egg Proteins; 0 / Glycoproteins; 0 / Liposomes; 0 / toposome glycoprotein complex; SY7Q814VUP / Calcium
  •  go-up   go-down


98. Taggar AS, Alnajim J, Anantha M, Thomas A, Webb M, Ramsay E, Bally MB: Copper-topotecan complexation mediates drug accumulation into liposomes. J Control Release; 2006 Aug 10;114(1):78-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Liposomes (1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and cholesterol (CH) (55:45, mole ratio)) were prepared with manganese (Mn), copper (Cu), zinc (Zn) or cobalt (Co) ion gradients (metal inside).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. MANGANESE COMPOUNDS .
  • Hazardous Substances Data Bank. Topotecan .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CHOLESTEROL .
  • Hazardous Substances Data Bank. COPPER, ELEMENTAL .
  • Hazardous Substances Data Bank. MANGANESE SULFATE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16842880.001).
  • [ISSN] 0168-3659
  • [Journal-full-title] Journal of controlled release : official journal of the Controlled Release Society
  • [ISO-abbreviation] J Control Release
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Buffers; 0 / Cations, Divalent; 0 / Lactones; 0 / Liposomes; 0 / Manganese Compounds; 0 / Phosphatidylcholines; 0 / Sulfates; 043IPI2M0K / 1,2-distearoyllecithin; 37H9VM9WZL / Calcimycin; 7785-87-7 / manganese sulfate; 789U1901C5 / Copper; 7M7YKX2N15 / Topotecan; 80168379AG / Doxorubicin; 97C5T2UQ7J / Cholesterol; RRU6GY95IS / Nigericin
  •  go-up   go-down


99. French AD, Fiori JL, Camilli TC, Leotlela PD, O'Connell MP, Frank BP, Subaran S, Indig FE, Taub DD, Weeraratna AT: PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci; 2009;6(2):93-101
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells.
  • Cytoplasmic expression of claudin-1 in metastatic melanoma cells correlates to increased migration, and increased secretion of MMP-2 in a PKC dependent manner, whereas claudin-1 nuclear expression is found in benign nevi.
  • Melanoma cells were transfected with a vector expressing CLDN-1 fused to a nuclear localization signal (NLS).

  • MedlinePlus Health Information. consumer health - Melanoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neuroreport. 2000 May 15;11(7):1427-31 [10841351.001]
  • [Cites] Methods Mol Biol. 2008;468:243-53 [19099260.001]
  • [Cites] Traffic. 2001 Feb;2(2):93-8 [11247307.001]
  • [Cites] J Cell Biol. 2002 Mar 18;156(6):1099-111 [11889141.001]
  • [Cites] Oncol Res. 2001;12(11-12):469-76 [11939410.001]
  • [Cites] Cancer Cell. 2002 Apr;1(3):279-88 [12086864.001]
  • [Cites] J Biol Chem. 2003 Jan 24;278(4):2692-700 [12403786.001]
  • [Cites] Am J Physiol Cell Physiol. 2003 Aug;285(2):C300-9 [12660149.001]
  • [Cites] J Biol Chem. 2004 Aug 20;279(34):35702-8 [15187091.001]
  • [Cites] Am J Pathol. 2005 May;166(5):1541-54 [15855653.001]
  • [Cites] J Biol Chem. 2005 Jul 15;280(28):26233-40 [15905176.001]
  • [Cites] J Clin Invest. 2005 Jul;115(7):1765-76 [15965503.001]
  • [Cites] Cancer Res. 2005 Nov 1;65(21):9603-6 [16266975.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H381-9 [16155104.001]
  • [Cites] Int J Immunopathol Pharmacol. 2006 Apr-Jun;19(2):287-91 [16831296.001]
  • [Cites] Oncogene. 2007 May 31;26(26):3846-56 [17160014.001]
  • [Cites] J Biol Chem. 2007 Jun 8;282(23):17259-71 [17426020.001]
  • [Cites] Mol Pharmacol. 2008 Aug;74(2):432-42 [18477669.001]
  • [Cites] PLoS One. 2008;3(7):e2715 [18648642.001]
  • [Cites] Cancer Res. 2008 Dec 15;68(24):10205-14 [19074888.001]
  • [Cites] Cancer Res. 2000 Nov 15;60(22):6281-7 [11103784.001]
  • (PMID = 19305641.001).
  • [ISSN] 1449-1907
  • [Journal-full-title] International journal of medical sciences
  • [ISO-abbreviation] Int J Med Sci
  • [Language] ENG
  • [Grant] United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / CLDN1 protein, human; 0 / Claudin-1; 0 / Membrane Proteins; 0 / Nuclear Localization Signals; EC 2.7.11.11 / Cyclic AMP-Dependent Protein Kinases; EC 2.7.11.13 / Protein Kinase C; EC 3.4.24.24 / Matrix Metalloproteinase 2; NI40JAQ945 / Tetradecanoylphorbol Acetate
  • [Other-IDs] NLM/ PMC2658888
  • [Keywords] NOTNLM ; Claudin / PKA / PKC / melanoma / metastasis
  •  go-up   go-down


100. Zarineh A, Kozovska ME, Brown WG, Elder DE, Rabkin MS: Smooth muscle hamartoma associated with a congenital pattern melanocytic nevus, a case report and review of the literature. J Cutan Pathol; 2008 Oct;35 Suppl 1:83-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Smooth muscle hamartoma associated with a congenital pattern melanocytic nevus, a case report and review of the literature.
  • Smooth muscle hamartoma (SMH) is a rare benign congenital or acquired lesion sometimes associated with Becker's nevus (Becker's melanosis).
  • We report an unusual lesion with combined features of SMH and melanocytic nevus.
  • The patient is a 49-year-old male with a history of a changing 'mole' on the left upper back.
  • The melanocytic component strongly expressed melanoma antigen recognized by T-cells-1 (MART-1) and HMB-45.
  • Unlike a recently reported case of SMH combined with a melanocytic nevus and basal cell carcinoma, the current lesion did not occur in association with a Becker's nevus.
  • [MeSH-major] Hamartoma / complications. Hamartoma / pathology. Muscle, Smooth / pathology. Nevus, Pigmented / complications. Nevus, Pigmented / congenital
  • [MeSH-minor] Actins / metabolism. Antigens, Neoplasm / metabolism. Calmodulin-Binding Proteins / metabolism. Humans. Immunohistochemistry. MART-1 Antigen. Male. Melanoma-Specific Antigens. Middle Aged. Neoplasm Proteins / metabolism

  • Genetic Alliance. consumer health - Nevus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright Blackwell Munksgaard 2008.
  • (PMID = 18544054.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, Neoplasm; 0 / Calmodulin-Binding Proteins; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Melanoma-Specific Antigens; 0 / Neoplasm Proteins
  •  go-up   go-down






Advertisement